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CHAPTER)
INTRODUCTION
Patients with end stage renal disease who are on hemodialysis must follow a strict
regimen including dialysis schedule, medication, a special diet, and fluid restriction.
These regimen conditions, especially the diet, require a significant lifestyle change for the
patient. Between 20 to 78% ofhemodialysis patients are non-adherent with their diet and
fluid restriction because of this alteration in their long.istanding personal habits (1). Non-
adherence to the diet was the direct cause of death in 4% ofhemodialysis patients, with
80% of the dialysis patients who died not following their renal diet (2). Patients who
make the appropriate lifestyle changes necessary for the adjustment to hemodialysis, may
improve their health and quality of life while on dialysis.
The dietary restrictions while receiving hemodialysis are very demanding, leading
to a high rate of non-adherence (3). Patients with end stage renal disease must limit and
control their intake of fluid and other elements of their diet such as protein, potassium,
and phosphorus (4). These nutrients are found in many foods that are a regular part of the
diet.
Inability to follow all regimen requirements is cornmon among people living
with chronic diseases (5). Adherence with dietary, fluid, and medication guidelines was
an important factor in the continued health and well-being of the patient undergoing
-chronic hemodialysis (6). Adherence with dietary restrictions, however was the most
difficult part of the entire medical regimen because it affected long-standing personal
habits and lifestyle. Patient non-adherence remained a very significant threat to the value
of recommended and prescribed treatments. Research has shown a few methods to
increase dietary adherence among the hemodialysis population (2,7).
Few educational tools and counseling methods have been studied when
conducting dietary counseling with the end stage renal disease (ESRD) population.
Lewis et a1. (7) developed a Spice of Life program that was implemented at one
outpatient hemodialysis center to facilitate the acceptance of the required renal dietary
sodium restriction. Hegel et a1. (2) used a reinforcement-based intetvention which
consisted ofincentives to follow the renal diet (e.g. lottery tickets, private television and
videotapes during dialysis). The Spice of Life program and reinforcement based
intervention were successful in dialysis patients (2, 7).
Illness intrusiveness and self-efficacy are psychosocial concepts hypothesized to
have an effect on adherence to medical regimens among persons with chronic diseases (8,
9). Few research studies have been conducted investigating these psychosocial theories
among the ESRD population.
Behavioral contracts have been used in a wide variety of disease states in order to
increase adherence with a variety ofbehaviors (10, 11, 12, 13). A few behavioral
contracts have been used with the hemodialysis population, however the effect of
behavioral contracting among dialysis patients has remained unconclusive (5, 14).
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Purpose and Objectives
The purpose of this study was to detennine ifbehavioral contracting was an effective
method to use when counseling hemodialysis patients to improve dietary adherence. The
following objectives were fonnulated for this study:
1. To determine if behavioral contracting improves dietary adherence ofhemodialysis
patients.
2. To determine if behavioral contracting increases self-efficacy of hemodialysis
patients to follow the renal meal plan and take phosphorus binders.
3. To determine if behavioral contracting will decrease illness intrusiveness of
hemodialysis patients.
Assumptions
The following assumptions were made:
1. It was assumed that the subjects completed all survey fonns honestly.
2. It was assumed that the subjects in the control group did not alter their eating habits
during the study.
3. It was assumed that the subjects completely reported daily food intake and these
records reflected their actual daily intake.
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CHAPTER II
REVIEW OF THE LITERATURE
The Renal Diet as Part of the Hemodialysis Regime
The kidneys clear waste products from the blood. When the kidneys are not
working properly, these waste "products build up in the blood. Dialysis is administered to
patients in order to rid the body of these waste products. These waste products are
derived from food consumed in the diet and metabolic processes. Several dietary
restrictions need to be applied in order to prevent an excessive accumulation of waste
products in the blood between dialysis treatments. Blood potassium and phosphorus are
two main blood parameters monitored in dialysis patients. Fluid weight gain is
monitored due to a decrease in urine output resulting from declined kidney function.
Protein nutritional status is monitored in the dialysis patient as protein waste products can
accumulate and the patient loses protein with each dialysis treatment.
The main source of potassium in the diet comes from fruits and vegetables (4).
Dialysis patients need to limit the intake of potassium to avoid a myocardial infarction.
The fruits and vegetables are divided into categories of low, medium, and high potassium
content. Many common fruits and vegetables, such as potatoes, tomatoes, bananas, and
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-oranges fall into the high potassium list and must be limited to very small amounts in the
patient's diet. Potassium is controlled because it can lead to hyperkalemia, causing .
cessation of the heart in the renal patient. The recommended potassium intake ranges
from 50-80 milliequivalents (2500-300Omg) per day (4). The amount of potassium a
person can tolerate depends on individual residual kidney function, body size, presence
of anabolism, catabolism, infection, and potassium content of the dialysate.
The main source of phosphorus in the diet is found in dairy products (4). The
dietary restriction for phosphorus requires the renal patient to limit their consumption of
dairy products to one serving per day. Patients are instructed to keep the dietary
phosphorus intake to 1000 to 1200 milligrams per day (4). Phosphorus can cause bone
disease if a patient remains non-adherent to the dietary restriction. This restriction is vital
because of the increased level ofhigh-phosphorus meats the patient must C()nsume to
maintain an adequate protein intake and keep their albumin level within a normal range.
Phosphorus retention, resulting in hyperphosphatemia, plays a major role in the
development of secondary hyperparathyroidism and renal osteodystrophy. In addition to
phosphorus dietary restrictions, patients need to consume phosphorus binders with every
meal to help keep blood phosphorus levels within acceptable range. The phosphorus
binder binds to phosphorus in foods consumed, preventing absorption of phosphorus into
the body.
The protein requirement of a patient undergoing chronic hemodialysis is greater
than the Recommended Dietary Allowance because some amino acids and peptides are
removed during dialysis (4). The National Kidney Foundation recommended a protein
intake of 1.2-1.4 gramslkilogram ideal body weight, depending on the patient's
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-nutritional status. Good sources of high biological value protein come from animal
products. Most dialysis patients consume chicken, eggs, fish, turkey, and red meat in
order to meet their protein requirement.
Most dialysis patients become oliguric or anuric after beginning dialysis
treatments. As urine output decreases, fluid is retained in the body. This fluid retention
can lead to congestive heart failure, edema, and elevated blood pressure. Therefore, a
fluid restriction must be given to the patient to avoid fluid overload. A typical fluid
restriction falls between 1000 to 1500 milliliters per day, or four to six cups of fluid per
day based on the patient's urine output (4). The fluid restriction is determined by adding
urine output to one liter, resulting in the total fluid allowance for the day.
Factors Influencing Adherence
Adherence with dietary, fluid, and medication guidelines is a significant factor in
the continued health and well-being of the patient undergoing hemodialysis (6).
Adherence is defined as the extent to which an individual chooses behavior that coincides
with a clinical prescription. The lifestyle of hemodialysis patients is severely altered by
the treatment regimens of kidney fai.lure. Adherence with the dietary restriction is
probably the most difficult part of the whole medical regimen because it affects long-
standing personal habits and alters lifestyle much more than taking pills. To obtain
adherence there must be: 1) motivation; 2) individualization; 3) presentation of the diet
by qualified and motivated people; and 4) suitable forms (ex. weekly menus). Several
factors have been found to influence a patient's level of dietary adherence, such as
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psychological stress, economics, social situations, demographics, and personal
characteristics (6).
Food and fluid limitations create considerable psychological stress, as well as
detracting from the quality oflife (6). Wright et al. (15) defined three categories of
psychosocial stress experienced by ESRD patients. The first stress was due to the real or
threatened decrease in economic status, possibly due to a lost job (6, 15). Also connected
to the economic status was the accumulating medical expenses with dialysis and the loss
of social roles (15). The second category of stress the patient experienced as a result of
hemodialysis included physical injury, pain, loss of urinary function, sexual dysfunction,
and the lack of acceptance of the dialysis shunt (15). The last stress has to do with the
frustration of drives. The frustration of drives can be explained by the restrictions that
are placed on the diet, medicine, and increased dependency on the medical staff and
family (15). Nilofer et a1. (1) concluded that depression was also a psychosocial factor
contributing to non-adherence. Patients feel blocked in their desire to deal with
emotional consequences of their role in the dialysis process (i5). Devins et al. (16) found
that physical, demographic, and psychosocial variables contributed to the prediction of
survival in ESRD. King (17) concluded psychosocial factors associated with non-
adherence among the elderly involved social isolation. home environment, lack of
transportation, limited income, illiteracy, mental status, and family dynamics.
Several patient characteristics can influence dietary and medical tre-atment
adherence. Eddins (18) identified certain patient characteristics that tended to increase
dietary and medication adherence among dialysis patients. These characteristics
included acceptance of the illness, no placement ofblame was put on others, and the
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acceptance of the responsibility of care (18). Non-adherent patients viewed their illness
as an enemy or burden that rendered them defenseless (18). Non-adherent patients
experienced negative feelings predictive ofnon-adherent tendencies with diet and
medication recommendations (18). Non-adherent patients displayed a stronger tendency
than adherent patients to affinn their positive self attributes or accomplishments (1).
Non-adherent patients use "defensive distortion" or blaming the illness, medical staff, or
lifestyle changes for their non-adherence to the dietary and medication regimen (1). A
patient's gender and role in their health care also played a role in their level of adherence.
A study by Nilofer et a1. (I) found that predictors of non-adherence to diet and fluid
regimens include: male gender, and not feeling responsible for one's own well-being.
One factor that consistently predicts adherence is locus of control (19). Locus of
control refers to the degree to which individuals perceive events in their lives as being
consequences of their own actions. Patients with an internal locus of control believe their
actions have causal relationships which produce consequences. While patients with an
external locus of control relate events to external forces such as fate and chance. Dialysis
patients with an internal locus of control have been found to comply more with their
medical regimen.
-Age as an influence on adherence
King (17) and Lewis et aI. (7) discovered factors that affected the degree of
dietary adherence among elderly hemodialysis patients. The elderly patients experienced
events that occur with the aging process such as vision and hearing ~oss, decrease in
mental activity) and loss of manual dexterity (7,17). These events tended to decrease the
elder's level of adherence, despite their knowledge of dietary restrictions (7). Social
isolation increased with age due to death of friends, family, and significant others causing
a tendency to be nonadherent (17).
Nilofer et aI. (1) also found that being older decreased the level ofdietary
adherence among ESRD patients. Teal et a1. (20) found that an increase in age was a
predictor ofnon-adherence as measured by serum potassium and albumin. Lack of
patient education has also been directly associated with non~aldherence in the elderly
population (7).
Devins et a1. (16) found that longer survival times were associated with patients
who had fewer serious comorbid non-renal illnesses (diabetes) hypertension. pulmonary
diseases), were younger, engaged in a higher number of leisure activities on a regular
basis, and experienced an even mixture of happiness and unhappiness (16).
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-Demographic factors as an influence on adherence
Several demographic factors have been shown to influence dietary adherence in
the ESRD population. Several studies found that patients who were married were more
dietary adherent than single patients (1, 5, 6, 16). O'Brien (21) also found that married
patients tended to adhere to the diet, while single patients had higher levels ofnon-
adherence (21). In contrast, patients who had never been married before demonstrated
the lowest levels of dietary adherence (21).
Less education has also been found to be a predictor of nonadherence (1,5,6, 7,
22). Patients who received more education in school tended to have higher levels of
dietary adherence. The most compliant patients tended to be skilled professionals with a
high level of self-concept (6, 7).
Dialysis patients with a lower socio-economic status were frequently found to be
non-adherent (6, 7). Wichowski and Kubsch (22) found that an inability to afford
treatment and limited access to treatment resulted in a higher level of dietary non-
adherence.
Patient education regarding the dietary restrictions for hemodialysis may not be
associated with dietary adherence. Hoover (6) found that a patient's level of knowledge
regarding dietary and fluid regimens was not significantly associated with adherence.
Family dynamics and social support have been shown to have an effect on
adherence in ESRD patients. O'Brien (21) found that the type of household had some
effect on the level of adherence among dialysis patients. Persons living with other adults
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and children were more adherent to the renal diet, while those living alone were least
adherent to the diet (21). Caregiver and family support also contributed to higher levels
of adherence (21). Wichowski and Kubsch (22) identified lack of family support as a
contributor to dietary non-adherence. Pijls et a1. (23) found that patients with type 2
diabetes who lived alone tended to have a higher rate of dietary adherence to a lower
protein intake of 0.8 grams per kilogram ideal body weight than the patients who lived
with other people.
Measuring Adherence
Adherence to the treatment regimen in hemodialysis patients is most often
measured by monitoring blood levels of urea nitrogen (BUN), potassium, phosphorus,
and by observing the amount of weight gained between dialysis treatments or
interdialytic weight gain, and assessing food intake (5,20). Adherence or non-adherence
to the dietary and fluid regimen can be difficult to determine. For example, a patient's
blood potassium level can increase with infection or muscle breakdown. In addition, if
the patient consumes too much potassium in their diet, their blood potassium level will
rise. The blood potassium level could also decrease due to no muscle wasting and lower
potassium in the diet. Gentile et al. (24) suggested biochemical data can evaluate both
nutritional status and dietary adherence. Gentile et a1. (24) suggested anthropometric
data, biochemical data, and diet records be integrated into the adherence process.
Gentile et al. (24) published an article that analyzed the available instruments for
measuring dietary adherence in ESRD patients. Biochemical data can serve to evaluate
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-both nutritional status and compliance. BiochemicaJ tests are available to measure
potassium, phosphorus, and albumin levels. Diet history can be used to evaluate the
dietary habits of patients. A diet history can uncover food choices which have an effect
on a patient's level of dietary compliance (24). Adherence to a diet was not a simple
task, and required a lifestyle change.
Blood potassium was used as an adherence indicator because it represented both
dietary protein, fruits, vegetables, and high potassium desserts. Dietary potassium was
not the only factor that could cause the potassium level to rise. Some other contributing
factors leading to increased blood potassium were muscle wasting and infection. Blood
potassium has been used in multiple studies as an indicator of potassium adherence in the
diet (19, 25, 26, 27). Brown and Fitzpatrick (19) used blood potassium levels to assess
potassium intake and adherence points were assigned to subjects based on their blood
potassium level. Blackburn (25) used blood potassium to detennine potassium dietary
adherence among hemodialysis patients. Blackburn (25) defined a patient to be adherent
with dietary potassium restrictions when their blood potassium was 3.5 to 5.0
millequivalents per liter. Research by Kobrin et a1. (26) involved obtaining a monthly
serum potassium level to determine dietary adherence levels among hemodialysis
patients.
Patients are instructed to consume one dairy product per day, keeping the
dietary phosphorus intake at 1000 to 1200 milligrams per day (4). Studies defined
subjects as being dietary phosphorus adherent when blood phosphorus was 3.5 to 5.0
milligrams per 100 milliliters (21), less than 8.0 milligrams per deciliter (27), and less
than 5.9 milligrams per deciliter (5). Blackburn (25) and Kobrin et a1. (26) included
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blood phosphorus as an indicator ofdietary phosphorus conswnption. Sboenfeld et al.
(27) also determined patients' phosphorus adherence by using the laboratory parameters
for phosphorus of less than 8 milligrams per deciliter derived from the National
Cooperative Dialysis Study (NCDS) (27).
Dietary protein is essential to maintain adequate nutritional status. Dialysis
patients need to consume more protein than the average person due to the protein lost
from the dialysis treatments. Compher (28) defined adequate nutritional status when
albumin levels were 3.1 to 4.2 milligrams per deciliter. Compher (28) used serum
albumin and body weight as part of their regimen to assess the nutritional status in
chronic renal failure patients. The study used the laboratory parameters for albumin, 3.5
to 5.5 grams per deciliter, derived. from the National Cooperative Dialysis Study (NCDS)
(27).
Interdialytic weight gain has been used as an indicator of fluid adherence in
studies (26). Interdialytic weight gain was calculated by figuring the difference between
the predialysis weight and post dialysis weight from the previous treatment (26).
Excessive fluid weight gain in between dialysis treatments placed a patient at greater risk
for cardiac stress, edema, and pulmonary complications (26). If the patient exceeded the
dietary sodium restriction, the level of thirst increased (26). Most of the fluid consumed
to quench thirst was retained within the hemodialysis patient due to an inability to
produce urine, reflecting in an increased interdialytic weight gain (26). Studies have
defined fluid adherence as when the following interdialytic weight gains were measured:
4 pounds per day (27), or less than 6.6 pounds per treatment on weekdays and less than
8.8 pOWlds per treatment over the weekend (5). Blackburn and Kobrin (26) calculated
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-interdialytic weight gain to determine fluid and sodium adherence. Schoenfeld et aI. (27)
used an interdialytic weight of less than or equal to 3.5 kilograms between treatments as
derived from the National Cooperative Dialysis Study (NCDS).
Dietary assessment is a necessary part of evaluating a patient's nutrient intake and
is also used for assessing adherence to the renal diet (I). Dietary assessment measures
the quantity and quality of food consumed over a period of time. The accuracy of dietary
assessment instruments to measure changes in dietary behavior of the patient population
under study should be considered in nutrition-intervention research (29). There are two
types of dietary records: the food record a patient completes and the food record filled in
by an experienced interviewer (31). A diet record kept by a patient does not have good
reliability because it can be difficult to quantify one's dietary intake (23, 29, 32). Food
records that cover more than three days might not be as reliable due to the problem of a
fading memory with recall (3 1). A questionnaire filled in by an experienced interviewer
proved to be more reliable, but needed a registered dietitian or nurse to administer it (32).
The twenty-four hour recall can be quick and easy to administer, but does not record
typical intake due to daily variations in intake (32). Food models, pictures, and analogies
can help patients quantify serving sizes, increasing the validity of the twenty-four hour
diet recall (32). An analogy compares a food portion to an everyday object. For
example, comparing a three ounce serving of meat to the size of a deck of cards.
The food frequency questionnairre (FFQ) consists of a list of food items for which
average frequency of consumption was determined by the subject in reference to a
specified time (33, 34, 35, 36, 37). Information on serving size as well as frequency of
consumption allowed for estimations of nutrient intake (33). FFQ can be used to
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determine habitual intake and therefore was especially effective in studies relating to diet
and chronic diseases (37). The FFQ appeared imprecise for estimating absolute nutrient
intakes but useful for identifying extremes of intake and monitoring trends in dietary
patterns over time (33). Although FFQ's have a tendency to overestimate intake, their
strength was in their high reproducibility (33, 36).
Counseling Methods and Tools
Lewis et al. (7) developed a program titled "Spice of Life: A Strategy to Enhance
Dietary Compliance". This program consisted of a pamphlet describing herbs and spices
and how to use them in cooking to enhance the flavor of food. The packets of spices and
herbs mentioned in the pamphlet were given to the patients to use in cooking. Eighty-two
percent of the 35 patients reported the pamphlet was helpful and the use of the spices
made the diet more palatable 75% or more of the time. This program encouraged
experimentation with seasonings and afforded the patients an opportunity to determine
their flavor preferences without the costly purchase of any undesired spices.
Hegel et al. (2) used a reinforcement-based intervention which consisted of
incentives to follow the renal diet and treatment regimen. Four chronic fluid overloaders
who gained more than 2 kilograms per 24 hours were selected to participate in the study.
If a patient succeeded in achieving an interdialytic weight gain of less than 2 kilograms
per 24 hours, they received a reward. The rewards included lottery tickets, private
television, and private videotapes. The rewards were provided to the patient during the
dialysis treatment. The rewards were ranked by preference, the patient who met the most
15
-stringent fluid weight gain, received the most preferred reward Subjects signed a
behavioral contract stating they would meet the minimum weight gain criteria. The
patient received the preferred incentive if they met their individualized 24 hour
interdialytic weight gain goal. The results of this study indicated that the incentives
helped to promote well-maintained and stable improvements in decreasing interdialytic
weight gain, but were not significant ( p< .02).
Behavioral contracting as a counseling method
Kirschenbaum and Flanary (1 J) define a behavioral contract as an explicit
agreement specifying expectations, plans, and/or contingencies for the behavior(s) to be
changed. Epstein and Wing (12) define the behavioral contract as a written agreement
specifying operationally defined behaviors and contingencies designed to promote
behavior change.
The four central elements of a behavioral contract include: J) the fonn of the
contract; 2) contract participants; 3) target behaviors; and 4) consequences (11, 12). The
form of the contract depends on whether or not the agreement is written or verbal,
negotiated or non-negotiated, individualized or standard, public or private (11). A
negotiated contract implies that the participant involved in the contract may alter the
contract, such as the target behaviors or perfonnance expectations defined in the contract.
An individualized contract is used when the contract is tailored to meet the specific needs
of the participant. When the conditions of a behavioral contract are only known to the
16
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participant, the contract is considered to be private (11). The contract participants are the
individuals to whom the contract applies. The target behaviors are the behaviors to be
changed. The target behavior may include changing eating and drinking habits to alter
the outcome of laboratory values and interdialytic weight gain, and this type of behavior
change is defined as a process goal. After the target behaviors have been defined, the
consequences must be decided if the target behavior was not achieved. Positive
reinforcement and negative reinforcement are most commonly used in the behavioral
literature as consequences to a behavioral contract (11). Some examples of positive
reinforcement found in the literature include money, lottery tickets, verbal praise, and
coupons (5, la, 11, 12,28,29,30,31,32,37). A patient experienced negative
reinforcement if the elements of positive reinforcement were not applied. For example,
the patient would not receive any praise from the dialysis staff (5).
Behavioral contracts have been used to facilitate behavioral changes in a wide
variety of health behaviors (11). Behavioral contracts have also been used in several
other areas of the health care field. The growing popularity of the behavioral contracts
may be due to the fact that contracts contain many factors that are suited to promoting
behavioral change. The development ofa behavioral contract defines the treatment
elements and target responses so it is possible to determine if the contract outcome was
met.
Many case studies have shown behavioral contracts to be useful in the attainment
of medical or dietary regimen (12, 13, 14, 38, 39, 40, 41). Several studies have linked
behavioral contracts with the ability to lose weight (11,41,42,43,44). A contingency
contract defines a reward or reinforcer that will be received by the individual or group if
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the outcome defined in the contract was reached (12). Contingency contracts have been
used to produce changes in eating habits or weight (12).
Several researchers successfully aided clients in losing weight using behavior,a]
contracts (12, 45). Jeffrey et al. (45) treated four subjects with behavioral contracts
which promoted weight loss. The client specified the magnitude of money to be
deposited, their goal weight, and the amount ofweight to be lost each week. Subjects
lost an average of 27 pounds in 24 weeks, but only two maintained the weight loss at the
six month follow-up (45).
Monti et a1. (46) illustrated the use of a contingency contract in the treatment of a
patient with bulemia and anorexia nervosa. The contract produced a period of weight
stabilization and calorie intake of 1800 to 2300 calories per day over a six month period,
with only six violations of the contract during this time.
A betw,een group design using an experimental and control group was used by
Harris and Hallbauer (47) that compared contracting and self-control procedures for
changing eating habits to promote weight loss. The subjects were divided into three
groups, eating behavior contract group, exercise and eating behavior contract group, and
a control group. Contracting subjects detennined the amount of weight to be lost in
return for money. The money was deposited into each subject's account in return for
every pound lost. After twelve weeks, subjects in all three groups lost approximately the
same weight, but the subjects in the two contracting groups lost significantly more weight
than subjects in the control group at the seven month follow-up.
Schlenk and Boehm (30) used contingency contracting persons with type 2
diabetes to promote positive behavior changes in their health care regimen. The behavior
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changes included: food intake, exercise, blood glucose monitoring, medication taking,
appointment keeping, smoking cessation, and self-reinfDrcement. Subjects self-reported
that they successfully perfonned 90.9% of all the above mentioned behaviors in the
contingency contracts. Patients were educated regarding their diabetic diet by a
registered dietitian and were supposed to participat.e in a specified amount of exercise
every week. Almost 60% ofthe subjects successfully foHowed the diet and exercise
behaviors.
Koch et al. (48) examined the use of behavioral contracting to improve
medication adherence in patients with thalassemia. An individual contract was drawn up
and signed by each patient. The contract defined the number of empty desferrioxamine
vials patients would return to the activity room to count towards fufillment of the
contract. Each time the patient returned with the pledged number of vials, a reward was
given and a new contract was made. The new contract challenged the patient to maintain
or increase the number of vials for the next two week period in between visits. Patients
who returned fewer vials than contracted, were not rewarded and encouraged to set a
more realistic goal for the next contract period. Twenty-three patients in the clinic
contracted and increased the use of their medication by an average of 1.23 days per week.
Four patients out of the contracting group that used the behavioral contract did not
increase the use of their medicine but maintained themselves at their initial adherence
level.
Behavioral contracting has also been tested as a method for promoting
cardiovascular health behaviors in families (49). The families involved in the study
contracted to change their eating behaviors. Parents in the contract group decreased their
19
-"
~
blood pressure and body weight but not significantly more than the control group.
Alterations in blood pressure and the ponderex index of their children did not
significantly ,change. Blood pressure decfeased by an average of 10 mm Hg and no
increase in weig."1t was observ,ed in the children.
Stark et a1. (50) wrote a case study conducting a behavioral contract with a cystic
fibrosis patient in order to increase adherence with the chest physiotherapy treatments.
The patient was not completing the three chest physiotherapy treatments per day as the
doctor had prescribed. The patient and her mother signed a nine week behavioral
contract agreeing to a reward of skating or a movie if the patient completed three
treatments per day. As a result of the contract, the patient increased and maintained the
three physiotherapy treatments per day during the contract period. In addition, the patient
was still maintaining the treatment schedule after the contract period was tenninated at
the nine week follow-up.
Solanto et a1. (51) looked at using b.ehavioral contracts with patients with anorexia
nervosa. The behavioral contracts were signed by the patient upon admission and
specified an amount of weight to be gained by the patient within the first fOUf days. The
patient would gain more ward privileges if the weight was gained. The two contracts
differed only in the weight gain criterion of either 0.8 pounds in four days with contract 1
and 1.2 pounds in four days with contract 2. Patients that received contract 2 (l.2 lbs)
gained more weight than those receiving contract 1 (0.8 Ibs) over the four days.
Research involving the use of behavioral contracting in chronic hemodialysis
patients is lacking. Keane et a1. (52) reported two case studies involving behavioral
contracts with two dialysis patients in order to improve their dietary adherence. Each
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patient received different contingency contracts to improve the degree of adherence to
their respective dietary restrictions. Subject one had a history ofnot restricting fluid
intake between dialysis sessions. The criteria of adherence for this patient was set at an
interdialytic weight gain of 2.5 kilograms for Monday sessions and 1.5 kilograms for
Wednesday and Friday sessions. A behavioral treatment program consisted of 1) staff
praise and social interaction reward when the criteria was met, 2) the patient graphing
interdialytic weight gains, and 3) a behavioral contract between the patient and the nurse.
Subject two had a history of uncontrolled interdialytic weight gains. The weight gain for
the criteria of adherence was set at a 3 kilogram weight gain for Wednesday and Friday
sessions and 3.5 kilograms weight gain for the Monday session. Through interviews with
the patient the dialysis staff learned that meals would be a powerful reinforcer for the
fluid gain in this patient. The dialysis staff offered the patient preferred foods in the
dialysis center in return for restricting fluid intake and meeting interdialytic weight goals.
Failure to meet the criteria resulted in the staff offering a breakfast that did not contain
the foods the patient desired. Behavioral contracting between the dialysis patient and the
staff of the treatment unit effectively reduced interdialytic weight gain by an average of
.75 kg for the two dialysis patients.
Tanner et a1. (5) used behavioral contracts in ESRD patients to determine the
effect on self-efficacy and adherence to phosphorus and fluid restrictions in the diet. A
monthly written contract was used by the investigator to assist the patients in developing
one or two monthly goals to improve their fluid and blood phosphorus levels by
restricting fluid intake and phosphorus, respectively. Patients received positive social
reinforcement from the dietitian and staff if they met their contract goal. The benefits of
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-using a behavioral contract as a means of increasing self-efficacy in this population were
inconclusive. No significant differences between the control and experimental group
were found. The behavioral contracts had little effect on patient self-efficacy and health
beliefs.
Illness intrusiveness
End stage renal disease and its treatment by dialysis is believed to introduce
significant psychosocial issues and adaptive demands for the patient. One of these
psychosocial issues is the concept of illness intrusiveness. Illness intrusiveness relates to
the degree to which an illness and its treatment may interfere with important facets of a
person's life (8). Increased patient involvement in self-care has been encouraged because
it is believed that patient participation may reduce the negative emotional impact of end
stage renal disease by restoring a sense of control to the patient, thereby, reducing stress
(53). Patient involvement in their care is proposed to increase their perception of control
over their illness, health, and over other life dimensions. In this way, increased patient
participation in treatment is believed to promote positive psychosocial adjustment and
contribute to the individual's subjective well-being and quality oflife. Intrusiveness
derives from illness-produced disruptions. Common stressors to all ESRD patients
include the constant threat ofdeath, reduced life expectancy, dependencies on medical
machinery and personnel, and decreased physical strength and stamina. A variety of
illness variables have been hypothesized to contribute to illness intrusiveness.
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Disruptions may be introduced as a result of the illness, which intenupts the ongoing
involvement of activities and interests that are important to the patient. Some of the
disruptions in end stage renal disease are diet, fluid restrictions, medicine, dialysis
treatments, and sensory deficits (53).
Illness intrusiveness is measured by the "Illness Intrusiveness Rating Scale"
developed by Gerald Devins (54). This scale was developed to measure illness-induced
interference with lifestyle, activities, and interests. When the scale was applied to end
stage renal disease patients, this self-reporting questionnaire obtained ratings of the extent
to which the illness and its treatment "interfere" with each of thirteen life domains,
related to quality oflife. Another study measured illness intrusiveness scores over eight
life domains, such as family life, work, recreation, etc. (55).
Several research studies were conducted to understand the role illness
intrusiveness (II) plays in ESRD. One study examined 101 ESRD patients to test the
hypothesis that the psychosocial impact of restless sleep was mediated in chronic illness
by illness intrusiveness (56). Results indicated that individuals who had restless sleep
reported a significantly higher level of illness intrusiveness (II score = 43.8) versus those
subjects who had good sleep (II score = 32.5) (56).
Quality oflife studies investigated the hypothesis that patients who have
previously experienced the failure of a transplanted kidney are characterized by lower
levels of quality of life than patients that have not experienced a failed transplant (55, 57,
60, 61). The first study measured illness intrusiveness in terms of pain by using the
McGill Pain Questionnaire (57). The second study expanded the illness intrusiveness
survey to measure eight life domains (55). The eight life domains included health, diet,
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work, active recreation, passive recreation, financial situation, spousal relationship, and
sex life (55). Higher levels of perceived illness intrusiveness were found in these studies
but did not reach a level of statistical significance (57, 60, 61).
A study by Devins et al. (58) compared the level of perceived illness intrusiveness
among ESRD patients who were on hemodialysis, continuous ambulatory peritoneal
dialysis, or were a kidney transplant recipient. Post transplant patients' reported
perceived illness intrusiveness (II) scores (24.4) that were significantly lower (p< .01)
than the hemodialysis patients' mean score of35. 9 and the CAPD patients mean score of
37.1. This study also found that the life domains of diet and physical well-being were
affected the most by end stage renal disease. Total II was significantly associated with
perceived time requirements (F.32, p<.001), uremic symptoms (r=.44, p<.001), non-
renal health problems (F.37, <.001), fatigue (r=.45, p<.001), and difficulties in daily
living (F.53, p< .001). Satisfaction and happiness indicators of perceived II were
significantly correlated with decreased levels of life satisfaction (F-.25, p<.025), positive
affect or pessimism (r=-.24, p< .050), and self-esteem (r=-.37, p< .01). [ncreased levels
of intrusiveness were also found with higher levels ofpessimism (F.24, p< .025) and
illness related concerns (F.55, p<.OOl). Elevated levels of perceived II were
significantly associated with increased levels ofdepression (F.33, p< .010) and negative
affect (F.33, p< .01).
One study assessed whether a person's self concept as a chronic kidney patient
controls the psychosocial impact of illness intrusiveness across the life span (59). Some
investigators have speculated that the day to day experience of a chronic illness and its
treatment exert an influence on the patient's self concept, leading patients to define
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themselves in tenns of their chronic disease and its treatment (59). The psychosocial
impact of illness intrusiveness is moderated in ESRD by the sel f-concept as a chronic
kidney patient and by age (59). The relation between illness intrusiveness and
psychosocial well-being differed significantly between younger and older patients
depending on whether they perceived. themselves as similar or dissimilar to the chronic
kidney patient (59).
Another research study hypothesized that multiple episodes of headaches and
muscle cramps in ESRD patients increased their perceptions of illness intrusiveness and
decreased their quality ofhfe (62). The levels of illness intrusiveness were significantly
higher when both muscle cramps and headaches occurred during one or more assessment
intervals (62). IHness-related concerns and general feelings of negativity were also
significantly higher among patients who experienced multiple episodes of muscle
cramping (62).
Self-efficacy
Self-efficacy was defined as a personal conviction that one has the specific
ability to execute a certain behavior or perfonn adequately in a given situation (9, 63, 64,
65). Self-efficacy reflects people's thoughts about their capability to perform certain
behaviors (65). It was hypothesized that expectations of personal self-efficacy, or one's
belief in their ability to perfonn a task, determined whether coping behavior wi 11 be
initiated, how much effort will be expended, and how long it will be sustained in the face
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ofobstacles and aversive experiences (9). Bandura (65) postulated four principal sources
of self-efficacy infonnation: 1) past and present perfOlmance accomplishments; 2)
vicarious experience ofobserving others perform; 3) verbal persuasion and other kinds of
social influence; and 4) states of physical arousal. Perception of self-efficacy influences
choice of activities. People avoid activities that they believe exceed their coping
capabilities (67). For example, if a dialysis patient believed dietary adherence was
beyond their capability, dietary non-adherence would be maintained.
There is little research on the effect ofESRD on dietary self-efficacy. Lower
levels ofdietary self-efficacy over time have been associated with increased depression
and low self-esteem in hemodialysis patients (68). Hemodialysis patients' dietary self-
efficacy scores have been found to be significantly correlated with actual past dietary
adherence and current dietary adherence (69).
Caesar (70) conducted a study on predicting dietary adherence in hemodialysis
patients by examining locus of control and ~elf-efficacy. Twenty-four hemodialysis
patients completed the patient self-efficacy questionnaire (PSQ). The PSQ was used to
determine the patient's self-efficacy for fluid intake restrictions. A high PSQ score meant
the patient had a higher fluid self-efficacy beliefs. Test/retest correlation coefficients
over one week and one month intervals were F.80 and r= .70, respectively. Fluid
adherence was defined by an average interdialytic fluid weight gain of less than two
kilograms. The mean PSQ self-efficacy score for the hemodialysis patients was 80.3.
The results indicated that fluid restriction self-efficacy was not correlated with fluid
restriction adherence.
Tanner et al. (5) used a self-efficacy! health belief survey to assess the
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perceptions of self efficacy for self-monitoring of phosphorus intake and
interdialytic weight gain, and subjects' beliefs and attitudes toward health before and
after receiving an intervention. In an attempt to improve phosphorus dietary adherence,
the intervention group participated in a monthly behavioral contract with the dietitian.
The experimental group also received a "report card" that dealt with phosphorus and fluid
adherence. The control group did not have the behavioral contract, but received a
monthly laboratory report that included the same dietary counseling as before. The
behavioral contract served as a tool to help the patient to set a dietary goal. Forty
hemodialysis patients participated in the study. The self-efficacy/health belief survey
was administered during the first and sixth month of the study to both the experimental
and control group. The survey was used to assess self-efficacy at baseline and post-
intervention. If self-efficacy was related to adherence, each time the patient achieved the
dietary goal on the behavioral contract, their self-efficacy or belief that dietary adherence
could be achieved should increase. Therefore, if a patient met their behavioral contract
goal, they would have a higher level of self-efficacy and increased dietary adherence.
The phosphorus and fluid values were reported to the patients on a report card. The
patient received a smiley face if adherent to the phosphorus or fluid restriction and a
frown if they were non-adherent to the phosphorus or fluid restriction. Adherence was
said to be present if interdialytic weight gain was less than 3 kilograms on weekdays and
less than 4 kilograms on weekends. Phosphorus adherence was present ifblood
phosphorus was 5.9 milligrams per deciliter or less. The self-efficacy scores were
interpreted as follows: 13 to 14 = high self-efficacy, 15 to 26 = moderate self-efficacy
and 27 to 29 = low self-efficacy. Results indicated that the control and intervention
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group had similar phosphorus and fluid self-efficacy beliefs at baseline (18.80 and 18.43,
respectively). A slight decrease in fluid and phosphorus self-efficacy occurred in the
control group, but was not significantly lower than the intervention group (17.90 versus
18.43, respectively). Patient adherence levels remained the same throughout the study.
These results indicate that the usefulness of behavioral contracts as self-monitoring tools
among ESRD patients remains unclear.
Summary of Review of Literature
Behavioral contracting has been successful among a wide variety of health
conditions. Behavioral contracting among the ESRD population has proven to be
inconclusive (2, 5). Improved fluid adherence has been found in cases where behavioral
contracting was successful (2). Behavioral contracting could prove to be an effective tool
in improving dietary adherence among the ESRD population.
Limited research has been conducted with self-efficacy and health beliefs in the
ESRD population. The effects of self-efficacy/health beliefs on dietary adherence among
the ESRD population remains inconclusive. If sel f-efficacy/health beliefs increase with
hehavioral contracting, dietary adherence might improve among the ESRD population.
Illness intrusiveness levels have been defined among the ESRD population.
ESRD subjects who experienced complications with their hemodialysis treatment had a
higher level of illness intrusiveness than those subjects who did not experience
complications with hemodialysis. Ifillness intrusiveness levels decrease with behavioral
contracting, dietary adherence might improve among the ESRD population.
28
CHAPTER III
METHODS
Purpose and Objectives
The purpose of this study was to detennine if behavioral contracting was an
effective method to use when counsehng hemodialysis patients to improve dietary
adherence. The following objectives were [onnulated for this study: to determine if
behavioral contracting improves dietary adherence of hemodialysis patients, to determine
if behavioral contracting increases self-efficacylhealth belief of hemodialysis patients to
follow the renal meal plan and take phosphorus binders, and to detennine if behavioral
contracting will decrease illness intrusiveness of hemodialysis patients.
Research Design
Subjects
Twenty-four volunteers from the hemodialysis unit at Saint Francis Hospital
participated in the study. Two subjects who volunteered for the study were not enrolled
because they had not been on dialysis for a year which resulted in twenty-two subjects
being randomized into the control or intervention group. The subjects were recruited by
flyers (Appendix A) and the dialysis staff. Inclusion criteria included being on dialysis
for at least a year. 35-<;)0 years old, not on enteral or parenteral nutrition, and able to
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communicate with the dietitian and complete the required surveys. After explaining the
study to subjects, a signed informed consent was obtained from each subject (Appendix
B). The protocol was approved by the Institutional Review Board of Oklahoma State
University and Saint Francis Hospital (Appendix C).
Experimental Design
This study was an experimental repeated measures design with an intervention
and control group. The subjects were randomly assigned to the experimental or control
group after the collection ofbaseline data. Subjects names were randomly drawn out of a
hat by the principal investigator in order to determine randomization to the experimental
or control group. Measurement of data took place monthly for some measures, and 0 or
baseline, month 3 or mid-point, month 6, and month 8 or post for other measures (Table
1). The study lasted approximately 10 months. Subjects completed a food frequency
questionnaire every month with assistance from the dietitian. After collection of the
delayed post measures, the control group had the option of entering into a behavioral
contract with the dietitian.
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Control and Behavioral Groups
The control group received their regular regimen of dialysis treatment including
medications, diet, fluid restriction, monthly laboratory review, food frequency
questionnaire, and treatment schedule. The behavioral group received their regular
regimen of dialysis treatment, monthly laboratory review, and in addition made a
behavioral contract with the renal dietitian (Appendix D) and received feedback from the
renal dietitian regarding the results of the food frequency questionnaire (FFQ) during
months 0 to 6 of the study. In the contract the patient defined a dietary behavior to meet
dietary potassium, phosphorus, phosphorus binder, or fluid restriction goals. If a patient
was determined to be non-adherent to this self-selected potassium, phosphorus, or fluid
restriction goal, another dietary food goal was incorporated into the behavioral contract to
promote adherence.
Behavioral Contract
The dietitian and subject reviewed monthly laboratory data for adherence. If a
subject had a non-adherent lab value, the subject defined a dietary behavior change. The
dietary behavior change was to be conducted during the month in order to achieve an
adherent lab value for the following month. If the subject completed the dietary behavior
change and an adherent lab value was achieved, the dietitian marked the goal was met on
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the behavioral contract. Positive reinforcement in the fonn of verbal praise from the
dietitian or dialysis nurse was used to reward patients for meeting their dietary goals on
the behavioral contract.
Survey Instrwnents
The illness intrusiveness survey used in this study covered thirteen life domains
such as health, diet, work, family relations, etc. Each subject rated the degree to which
ESRD and it's treatment interfered with each of these thirteen life domains. Scores
ranged from one to seven for each life domain. An answer of one was defined as not
very much, where an answer of seven was defined as very much. Scores for the illness
intrusiveness survey ranged from thirteen to ninety-one. A score of thirteen was
interpreted as a low level of illness intrusiveness, where a score of ninety-one was
interpreted as a high level of illness intrusiveness. Mean scores in ESRD tend to center
around 36 for dialysis patients. Internal consistency reliability, indicated by coefficient
alpha (.80 to.88) was high in ESRD patients (8,54). The instrument has been validated
in chronically ill patients and can be completed within ten minutes (8, 53, 54, 55, 56, 57,
58).
The self-efficacy/health belief survey used in this study contained twenty-two
questions relating to ESRD dietary, fluid and phosphorus binder beliefs (5). The survey
was divided into two sections. The first nine questions were related to health beliefs,
with the remaining questions relating to self-efficacy. For the first nine questions,
subjects responded by circling a number between one and three. One was defined as very
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important, two was sometimes important, and three was not important. The remaining
questions were also answered by circling a number between one and three. However,
these answers were defined as one being all of the time, two being some of the time, and
three being none of the time. Scores on the self-efficacy/health belief survey ranged from
twenty-two to sixty-six. A score of twenty-two was interpreted as a high level of self-
efficacy/health belief, where a score of sixty-six was interpreted as a low level of self-
efficacy/health belief.
The food frequency questionnaire used in this study was modified for renal
patients (Appendix H). This food frequency questionnaire estimated dietary intakes of
potassium, phosphorus, and protein in grams. If the subject did not consume a food
everyday, but consumed it at least three times per week, it was counted as one daily
serving on the FFQ.
Overall Plan of Data Collection
Data collected from all subjects in this study included monthly laboratory data,
self-efficacy/health belief scale towards following the renal diet, illness intrusiveness
scale, dietary adherence using a FFQ, and phosphorus binder adherence. Blood samples
were drawn monthly from the patients in the dialysis unit and analyzed for levels of
potassium, phosphorus, and albumin. Potassium, phosphorus, albumin, and fluid weight
gain were reviewed four months retrospectively to provide the baseline data for the
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patients. The blood draws for laboratory data were part of the standard operating
procedure of the dialysis unit.
At baseline (month 0) all of the subjects completed a personal information sheet
(Appendix E), the illness intrusiveness scale (Appendix F), self-efficacy/health belief
scale (Appendix G), and a FFQ (Appendix H).
The following demographic data was collected at baseline using the personal
information sheet (Appendix E): respondent age, dry weight, gender, racial or ethnic
origin, household income, primary diagnosis leading to dialysis, length of time on
dialysis machine during each treatment, marital status, current medications affecting
dietary adherence, and primary nephrologist.
During months 0 to 6 and 8 all subjects completed a FFQ (Appendix H) that
determined dietary adherence. The renal dietitian determined phosphate binder
adherence during the monthly interview with each patient involved in the study during
months 0 to 6 and 8. The dietitian detennined phosphorus binder adherence by asking the
patient if they were taking their phosphorus binder with each meal and snack and
confirming the number of binders the patient was taking with each meal and snack. Dry
weight, height, and interdialytic weight gain were measured during baseline or month 0,
with dry weight and interdialytic weight gain measured during months 1 to 6 and 8.
These measurements were part of the standard operating procedures of the dialysis unit.
Baseline data collection took place during the month of June. Month six, the last
month ofbehavioral contracting, took place during the month of December. Post data
collection took place during the month of February. All subjects started and finished the
study at the same time.
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Every month blood samples were drawn from each patient to measure blood
values. Ten milliliters ofblood was obtained from the arterial side ofthe fistula or
catheter by the dialysis nurse. The blood sample was drawn through a Beckton
Dickinson 18 gauge needle, into a Beckton Dickinson syringe, and placed into a 4.5 ml
blood collection tube vacutainer (Beckton Dickinson, Franklin Lakes, NJ). The blood
collection tubes used a combination of PST gel and Lithium Heparin as the anticoagulant,
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tubes were sent to the laboratory for analysis at Saint Francis Hospital. All laboratory
values are plasma values.
AlbUIllin, potassium, and phosphorus concentrations in the blood samples were
determined using the Aeroset System (Abbott Laboratories, Abbott Park, IL). The
albumin BeG procedure was based on the binding ofbromescal green to human albumin
to produce a colored complex. The colored complex was measured at 628 nanometers
(nm) using the Aeroset System to reveal the albumin concentration (grams per liter) in
the blood sample. During the month of September 1999, the laboratory changed the
method of determining albumin concentration. As a result, the new normal albumin level
was set at > 4.2 gms per deciliter instead of:::: 3.5 gms per deciliter between month two
and three of the study. The biochemical analysis of phosphorus (milligrams per deciliter)
included organic phosphate reacting with ammonium molybdate to form a heteropolyacid
complex. The absorbance level at 340 nm was directly proportional to the inorganic
phosphorus concentration in the plasma sample. Potassium concentration (millimoles per
liter) in the plasma sample was determined by ion-selective electrodes for potassium. An
electrical voltage was developed across the membranes between the reference and
measuring electrodes in adherence with the Nernst equation. The voltage was compared
to previously determined calibrator voltages and converted into an ion concentration for
potassium. The patient was considered adherent to the potassium restriction if the plasma
potassium level was between 3.5 to 5.5 millimoles per liter according to Saint Francis
Hospital's Laboratory. Plasma phosphorus was used to measure excessive intake of high
phosphorus foods and adherence to phosphorus binder use. Adherence was obtained with
36
a plasma level of3.5 to 6.0 milligrams per deciliter according to Saint Francis Hospital's
Laboratory.
Anthropometric Data
Body weight in kilograms was obtained by weighing the patient on a Scaletronix
5005 stand on scale before and after the dialysis treatment. The interdialytic weight gain
was obtained by subtracting the predialysis weight from the previous post dialysis
weight. The interdialytic weight was measured in kilograms.
Dietary Intake Data
A food frequency questionnaire (FFQ) is a retrospective review of intake
frequency than can describe intake over the past day, wee~ or month (29). The FFQ
organizes food into groups that have common nutrients. Data collected on the FFQ can
be analyzed by the dietitian, resulting in estimates of grams of protein, milligrams of
potassium, and milligrams of phosphorus consumed. The amounts of protein, potassium,
and phosphorus were compared with the recommended intakes of 1.2 to 1.4 grams
protein per kilogram ideal body weight, 2500 to 3000 milligrams potassium, and 1000 to
1300 milligrams of phosphorus in order to determine dietary adherence. Subjects were
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assisted and given verbal instructions by a registered dietitian when answering the FFQ.
A set of non-biasing food models was used by each subject to complete the FFQ. The
food models for one cup, half cup, and one-fourth cup were prepared following the
instructions provided by Oklahoma State University's Cooperative Extension SeIVice.
Bags made from colored nylon net with a measured volume of dried beans were used to
code for different amounts. A green nylon net circle of 10 1/8 inches in diameter was
used for the one cup measurement. A red nylon circle of 7 'h inches in diameter was used
for a half cup measure, and a blue nylon net circle 6 'h inches in diameter was used for a
1/4 cup measure. A double layer of nylon net was hand sewn together on the outer edge
and filled with the corresponding amount of dried pinto beans. The thread was pulled
together to close the net bag and was tied shut. A rubber food model representing a 3
ounce hamburger patty was used to estimate protein servings.
Subjects estimated their daily intake of different foods represented on the daily
FFQ (Appendix H). If a subject did not consume a food every day, but consumed a food
at least 3 times a week, it was recorded as a serving on the food frequency form. An
additional question regarding adherence with phosphorus binders was added at the end of
the form. The dietitian determined that a patient was required to have taken their
phosphorus binder at least 90% of the time in order to circle the yes and to be considered
phosphorus binder adherent. The amounts of protein, potassium, and phosphorus were
totaled and recorded at the bottom ofthe survey. The experimental group was informed
of the total amounts of protein, phosphorus, and potassium consumed according to the
FFQ, whi Ie the control group was not.
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-Adherence Score
A total adherence score was developed using the monthly FFQ and laboratory
values. For the dietary adherence score, subjects received one point if their protein intake
was between 1.2 to 1.4 grams per kilogram ideal body weight, if potassium intake was
between 2500 to 3000 milligrams per day, and phosphorus consumption was between
1000 to 1200 milligrams per day. A maximum of three points was possible and a
minimum score of zero meant dietary non-adherence. Subjects also received a maximum
of three points for biochemical and fluid measures ofadherence. One point was received
for a plasma potassium value of3.5 to 5.5 millimoles per liter, interdialytic fluid weight
gain of 1 to 3 kilograms, and a plasma phosphorus level of3.5 to 6.0 milligrams per
deciliter. The minimum laboratory adherence score was zero with a maximum score of
three. The dietary and laboratory adherence scores were added together for a total
adherence score for the behavioral and control group. The total adherence scores ranged
from zero (non-adherent) to six (adherent).
Data Analysis
The illness intrusiveness rating scale used was developed by Devins (55).
Cronbach's alpha coefficient for the illness intrusiveness (n) scale for the present study
was .84. This compares favorably with work done by others where the Cronbach's alpha
for the II scale was found to be .80 to .88 (8, 55).
The self-efficacy/health belief scale used in the present study was derived from
Tanner et al. (5). The Cronhach's alpha coefficient for the total self-efficacy/health belief
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scale for the present study was found to be .78. Tanner et aI. (5) did not report an alpha
coefficient for the total self-efficacy/health bel ief scale. The Cronbach' s alpha for the
health belief portion of this survey in the present study was found to be .53. Tanner et aI.
(5) did not report an alpha coefficient for the health belief portion of the survey. Tanner
et el. (5) reported a Cronbach's alpha coefficient of .84 for the self-efficacy portion of the
survey.
Hypothesis
1. Potassium intake of behavioral group subjects will be lower than those in the control
group.
2. Phosphorus intake of behavioral group subjects will be lower than those in the control
group.
3. Protein intake (gms per lBW) of behavioral group subjects will be higher than those
in the control group.
4. Phosphorus binder compliance with prescription will be higher in the behavioral
group subjects than the control group.
S. Fluid weight gain values of the behavioral group subjects will be lower than those in
the control group.
6. Potassium laboratory values of the behavioral group subjects will be lower than those
in the control group
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7. Phosphorus laboratory values of the behavioral group subjects will be lower than
those in the control group.
8. Illness intrusiveness scores of the behavioral group subjects will be lower than the
control group.
9. Self-efficacylhealth belief scores for following the renal meal plan and take
phosphorus binders of the behavioral group subjects will be higher than the control
group.
10. Total adherence scores of the behavioral group will be higher than the control group.
The statistical analysis was completed using the SPSS version 9, Chicago Ulinois,
1999. Independent t-tests between the behavioral and control groups were conducted at
basel ine, month 6, and post (month 8). The level of significance was set at p < .05 for the
one tailed t-tests. The independent t-test was conducted due to the small number of
subjects participating in the research. Main outcome variables studied were illness
intrusiveness, self-efficacy/health belief, interdialytic weight gain, dietary phosphorus,
dietary potassium, dietary protein, plasma phosphorus, plasma potassium, dietary
adherence, laboratory adherence, and total adherence.
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CHAPTER IV
RESULTS
Characteristics of Subjects
Of the 24 subjects who volunteered for the study, 18 or 82% of the subjects
completed all phases of the study. Two subjects left the study because they received
transplants. One subject had a stroke and was omitted. One subject expired during the
study. Two additional subjects were dropped from the study due to extended
hospitalizations. Of the 18 subjects who participated in the study, 11 were male.
The majority of subjects involved in the study were white. Most of the subjects in
the behavioral group were single (67%), whereas most of the control group subjects were
married (58%). Most of the subjects took Phosio as their phosphorus binder, with an
average of two taken with each meal and one with snacks. Approximately half of the
subjects in the behavioral group had a primary diagnosis of other, with 42% of the control
group subjects having a primary diagnosis of diabetes. Household income tended to be
lower in the behavioral group compared to the control group. Mean age was 65 years in
the behavioral group and 58 years in the control group. The behavioral group had been
receiving dialysis for a significantly longer length of time (115 ±62 months) compared to
the control group (52 ± 38 months) (p<.05). Duration of daily dialysis treatments were
not significantly different between groups. Current dry weight was significantly different
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between groups (p<.05) with the behavioral group dry weight significantly lower than the
control group.
Dietary Intake Values
Estimated dietary potassium was found to be significantly different between
groups at month six using an independent t-test at p<.05 (Table 3). The behavioral group
estimated potassium intake was greater than the control group at month six. The
estimated potassium intake of the behavioral group was adherent at month six. (Dietary
potassium intake was considered adherent when between 2500 to 3000 milligrams per
day.)
Estimated dietary phosphorus intake was significantly lower in the control group
compared to the behavioral group at month six using an independent t-test at p<.05
(Table 4). Estimated dietary phosphorus intakes were not adherent in the behavioral
group during baseline, month six, and month eight. (Dietary phosphorus intake was
considered adherent when between 1000 to 1200 milligrams per day.)
Tables 5 and 6 summarize estimated dietary protein intake. Total estimated
dietary protein intake was significantly lower in the control group compared to the
behavioral group at month six using independent t-test analysis (p<.05) (Table 5 and 6).
The behavioral group was adherent to protein intake in grams per ideal body weight
during month 6. The control group was adherent to the protein intake in grams per ideal
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body weight at baseline. Adherence to the protein intake in grams per kilogram ideal
body weight was set at 1.2 to 1.4 gms protein per kg IBW.
Phosphate Binder Adherence
The behavioral group reported taking their phosphorus binders as prescribed
100% of the time throughout the duration of the study. The lowest percent of phosphorus
binder adherence was reported by the control group, with phosphorus binders being taken
only 83% of the time during months three, four, and five.
Interdialytic Fluid Weight Gain and Laboratory Values Between Groups
Interdialytic weight gain was not significantly higher in the control group
compared to the behavioral group at month eight using an independent t-test (p<.05)
(Table 7). The behavioral group remained adherent to the interdialytic weight gain at
baseline, month six, and month eight. The interdialytic weight gain by the control group
was non-adherent at baseline, month six, and month eight. (Interdialytic weight gain was
considered adherent when between one to three kilograms.)
The plasma potassium levels were not significantly different between the
behavioral and control groups using an independent t-test (p<.05) (Table 8). The
behavioral and control groups plasma potassium was considered adherent at baseline,
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month six, and month eight. (Plasma potasium values between 3.5 to 5.5 millimoles per
liter were considered adherent).
Plasma phosphorus levels were not significantly different between the behavioral
and control groups using an independent t-test (p<.05) (Table 9). The behavioral and
control groups plasma phosphorus was considered adherent at baseline, month six, and
month eight.
Plasma albumin remained constant throughout the study, with the exception of the
change in normal albumin level between month two and three (Table 10). The behavioral
group and control group plasma albumin levels were considered adequate nutritional
status. Plasma albumin was not significantly different between the behavioral and
control groups using an independent t-test (p<.05). The increase in albumin between
month two and month three was due to methodology changes in the lab.
S~ale Scores
The II scores were not significantly different between the behavioral and control
groups using an independent t-test at baseline, month six, and month eight (p<.05) (Table
II). Self-efficacy/health belief scores were not significantly different between the
behavioral and control groups using an independent t-test at baseline, month six, and
month eight (p<.05) (Table 12).
The laboratory adherence score was significantly greater in the behavioral group
compared to the control group at month eight using an independent t-test (p<.05) (Table
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13). The control group was considered non-adherent with interdialytic weight gain at
baseline, month six, and month eight resulting in a lower laboratory adherence score.
The dietary adherence score was significantly greater in the behavioral group
compared to the control group at month eight using an independent t-test (p<.05) (Table
14). Both the behavioral and control groups had non-adherent dietary protein intakes the
majority of the time. Estimated dietary potassium intake was considered adherent in the
behavioral group while in the control group it was non-adherent because estimated
potassium intake was below recommendations.
The total adherence score was significantly greater in the behavioral group
compared to the control at month eight using an independent t-test (p<.05) (Table 15).
Total adherence scores were below two throughout the study, with the exception of the
behavioral group scoring above three at month eight.
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Table 2. Demographic characteristics of subjects by behavioral and control groupSI.
Cbaracteristics Dropped Bebavioral Control
Subjects
% n % n % n
Gender
Female 50 3 50 3 33 4
Male 50 3 50 3 67 8
Ethnic Origin
White 84 5 67 4 75 9
Black 16 I 33 2 8 I
Asian / Pacific Islander 0 0 0 0 0 0
American Indian! 0 0 0 0 0 0
Alaska Native
Hispanic 0 0 0 0 8
Other 0 0 0 0 80
Marital Status
Single 33 2 67 4 42 5
Married 67 4 33 2 58 7
Current Phosphorus Binder
Turns 67 4 17 1 27 3
Phoslo 33 2 67 4 73 8
Other 0 0 17 1 0 0
Primary Diagnosis
Polycystic Kidney 17 1 17 I 17 2
Diabetes 67 4 0 0 42 5
Hypertension 17 I 33 2 17 2
Other 0 0 50 3 25 3
,)
Household Income ~.
<14,000 to 19,999 33 2 67 4 27 3
20,000 to 34,999 33 2 0 0 46 5
35,000 to > 45,000 33 2 33 2 27 3 ;:r
Mean~SD Mean±SD1 n MeardSD n "-
Age (years) 65 ~24 64.5 ± 16" 6 57.8 ± 12" 12 ".I'"
Length ofTime on Dialysis
,
)
(months) 108 ~ 104 115 ± 63" 6 53 ± 3gb 12 I
Duration of Dialysis Treaunents
(hours) 3.8 ~ 0.3 3.9 ± 0.2" 6 4.0tO.I" 12
No. of Treaunents per Week 3 38 6 38 12
No. of Binders Taken
Breakfast 2.3 ~ 1.7 2.0 to.6" 6 2.3 ±0.9" i2
Lunch 2.6 ~ 1.4 2.0 ±0.6" 6 2.1 ± l.l" 12
Dinner 2.5 ~ I.5 2.0 t 0.6" 6 2.3 ± 0.9" 12
Snacks 0.8 ~ 1.2 0.9 ± 0.7" 6 0.8 ± 0.8a 12
Current Dry Weight (kg) 70.2 ~ 30.8 61.2t9.8" 6 74.8+14.3" 12
'Percents were not significantly different between groups using Chi sEJuare analysis at p< .05.
2Mean ~ standard deviation
aMeans with different superscripts were significantly different between groups using independent I-test at
p<.05.
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Estimated dietary potassium intake by study group.Table 3.
Month
Baseline
Month 1
Month 2
Month 3 (midpoint)
Month 4
Month 5
Month 6 (last contract)
Month 8 (post)
Behavioral
(n=6)
mg
3083.3 ±752.1 1• a
2933.3 ± 1036.7
2233.3 ± 656.3
2816.7 ± IS4.1
2083.3 ± 248.3
2233.3 ± 776.3
2850.0 ± 625.3 a
2550.0 ± 493.08
Control
(n=12)
mg
2875.0 ± 118.7a
2260.0 ± 531.7
2450.0 ± 639.9
2440.0 ± 747.1
1970.0 ± 565.8
1880.0 ± 722.3
]983.3 ± 798.7b
2260.0 ± 823.S8
I Mean ± standard deviation.
aMeans with different superscripts are significantly different by group using independent t-
test at p< .OS.
Estimated dietary phosphorus intake by study group.Table 4.
Month
Baseline
Month 1
Month 2
Month 3 (midpoint)
Month 4
Month 5
Month 6 (last contract)
Month 8 (post)
Behavioral
(n=6)
mg
1283.3 ±471.91,a
1350.0 ± 649.6
991. 7 ± 30S.6
11333±310.9
1175.0 ± 356.0
11083 ± 381 J
15S8.3 ±504.48
1400.0 ± 375.5a
Control
(n=12)
mg
1654.2 ± 684.46
1105.0 ± 282.3
1200.0 ± 323.2
101S.0 ± 326.6
985.0 ± 231.0
825.0 ± 307.5
] ]54.2 ± 310.3b
1235.0 ± 4S0.3 8
IMean ± standard deviation.
aMeans with different superscripts are significantly different by group using independent
t-test at p< 05
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Table 5. Estimated dietary protein intake by study group.
Month Behavioral
(n=6)
Baseline
Month 1
Month 2
Month 3 (midpoint)
Month 4
Month 5
Month 6 (last contract)
Month 8 (post)
gms
71.2 ± 33.5 1,a
75.8 ± 45.5
52.7±21.6
66.7 ± 19.8
65.5 ± 22.0
54.2 ± 13.6
85.5 ± 37.6a
70.3 ±31.0a
Control
(n=12)
gms
98.5 ± 44.9a
64.9 ± 17A
66.8 ± 16.1
56.5 ± 15.7
57.3 ± 14.7
45.3 ± 20.2
59.33 ± 19.9b
69.0 ± 23.3 a
IMean ± standard deviation.
aMeans with different superscripts are significantly different by group using independent
t-test at p<.05.
Table 6. Estimated protein intake in grams per kg ideal body weight by study group.
Month
Baseline
Month 1
Month 2
Month 3 (midpoint)
Month 4
Month 5
Month 6 (last contract)
Month g (post)
Behavioral
(n=6)
gmslIBW
1.1 ± OA1,a
1.2 ± 0.5
0.8 ± 0.2
I. 1 ± 0.3
1.0 ± 0.3
0.9 ± 0.2
l.3±OAa
1.1 ± OAa
Control
(n=12)
gms/IBW
1.3 ± 0.6a
0.9 ± 0.3
1.0 ± 0.3
0.8 ± 0.3
0.8 ± 0.3
0.8 ± OA
0.8 ± 0.3b
0.9 ± OAa
IMean ± standard deviation.
aMeans with different superscripts are significantly different by group using independent
t-test at p<.05.
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Table 7.
Month
Interdialytic fluid weight gain by study group.
Behavioral
(n=6)
Control
(n=12)
Pre month 4
Pre month 3
Pre month 2
Pre month 1
Baseline
Month 1
Month 2
Month 3 (midpoint)
Month 4
Month 5
Month 6 (last contract)
Month 8 (post)
kgs
2.3± 1.5 1
2.4 ± 1.8
2.9 ±2.0
2.5 ± 1.5
2.8 ± 1.68
2.7 ± 1.9
2.9 ± 1.5
2.2 ± 1.5
2.6 ± 1.5
2.4 ± 1.3
2.9 ± 1.78
2.3 ± 1.38
kgs
3.3±1.1
3.4 ± 1.4
3.7±1.2
3.7 ±0.9
3.7 ± 1.03
3.3 ± 0.9
3.0 ± 1.3
3.8 ± 1.3
3.4±1.3
3.3 ± 1.0
3.7±0.88
3.8 ± 1.2b
IMean ± standard deviation.
8Means with different superscripts are significantly different by group using independent t-
test at p<.05.
•
:.
Table 8. Plasma potassium by study group.
Month
Pre month 4
Pre month 3
Pre month 2
Pre month 1
Baseline
Month 1
Month 2
Month 3 (midpoint)
Month 4
Month 5
Month 6 (last contract)
Month 8 (post)
Behavioral
(n=6)
mmolfL
5.1±0.81
4.9 ± 0.5
4.4 ± 0.4
4.9 ± 0.5
4.9 ± 0.68
5.3 ± 0.6
5.2 ± 0.8
5.0 ± 0.6
4.9 ± 0.4
5.6 ± 0.7
5.0±1.1 8
4.9 ± 0.78
Control
(n=12)
mmolfL
5.0 ± 0.7
4.8 ± 0.7
4.4 ± 0.5
4.9 ± 0.4
5.0 ± 078
4.8 ± 0.5
4.6 ± 0.4
4.7 ± 0.5
4.9 ± 0.4
4.7 ± 0.5
4.8 ±0.5 8
4.8 ± 0.68
i
I
I
i.:'
IMean ± standard deviation.
8Means with different superscripts are significantly different between group using
independent t-test at p<.05.
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'Mean ±standard deviation.
aMeans with different superscripts are significantly different by group using independent t-test
at p,.OS.
Table 9. Plasma phosphorus by study group.
Month
Pre month 4
Pre month 3
Pre month 2
Pre month 1
Baseline
Month 1
Month 2
Month 3 (midpoint)
Month 4
Month 5
Month 6 (last contract)
Month 8 (post)
Table 10. Plasma albumin by study group.
Month
Pre 4 months
Pre 3 Months
Pre 2 Months
Pre 1 Months
Baseline
Month I
Month 2
Month 3 (midpoint)
Month 4
Month 5
Month 6 (last contract)
Month 8 (post)
Behavioral
(n=6)
mg/dl
5.0± 1.3 1
5.1 ± 1.2
4.5±1.1
4.4 ± 1.3
4.3 ± 1.6a
6.1 ± 0.8
6.0 ± 1.6
4.8 ± 0.7
4.9 ± 1.2
4.4 ± 1.2
4.8 ± 1.7a
5.0 ± 0.9a
Behavioral
(n=6)
gms/dl
3.9±0.4 1
3.7 ± 0.3
3.8 ± 0.2
3.7 ± 0.5
3.7 ± O.la
3.8 ± 0.4
3.8 ± 0.3
4.3 ± 0.42
4.5 ± 0.3
4.4 ± 0.5
4.5 ± 0.3 a
4.2 ± 0.3 a
Control
(n=12)
mg/dl
5.1±1.9
5.0 ± 1.1
5.0 ± 1.4
4.9 ± 1.8
5.4 ± 1.3a
6.5 ± 2.1
5.9 ± 1.7
6.5 ±2.6
6.6 ± 2.4
6.1±2.0
5.5 ± 1.6a
5.4 ± 1.4a
Control
(n=12)
gms/dl
3.9 ± 0.3
3.7±0.3
3.8±0.2
3.7 ± 0.4
3.8 ± 0.2a
3.8 ± 0.3
3.8±0.3
4.4 ± 0.3
4.5 ± 0.3
4.4 ± 0.3
4.4 ± 0.2a
4.2 ± 0.2a
'Mean + standard deviation.
2Nonnal value for albumin changed due to a change in laboratory procedure
aMeans with different superscripts are significantly different by using independent
t-test at p<.05 .
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Baseline
Month 3 (midpoint)
Month 6 (last contract)
Month 8 (post)
42.8 ± 17.0"a
46.7 ± 17.8
41.7 ± 14.98
46.4 ± 21.r
Table 11.
Month
Dlness intrusiveness score by study group.
Behavioral
(n=6)
Control
(0=12)
35.2 ± 14.98
40.4 ± 18.3
41.4 ± 16.28
46.8 ± 22.08
'Mean ± standard deviation.
8Means with different superscripts are significantly different by group using independentt-
test at p<. 05.
Table 12. Self-efficacy/health belief score by study group.
Month Behavioral
(n=6)
Baseline
Month 3 (midpoint)
Month 6 (last contract)
Month 8 (post)
29.5 ± 5.8,,8
33.0±6.4
28.5 ± 4.68
31.0 ± 6.3 8
Control
(n= 12)
27.5 ± 3.88
28.8 ± 4.3
28.0 ± 4.38
31.2 ± 6.4a
)
,'"
J
}
I
...
I
'Mean ± standard deviation.
8Means with different superscripts are significantly different by group using independent
t-test at p<.05.
.
.
Control
(n=12)
0.7 ±0.58
0.8 + 0.7a
0.5 :+ 0.7b
0.7 ±0.5 1,8
0.7 ±-0.88
1.8 + 1.08
Laboratory adherence score ~y_s_tu_d--"-y---,,g__r_ou-,pL-' _
Behavioral
(n=6)
Baseline
Month 6 (last contract)
Month 8 (post)
'Mean ± standard deviation.
aMeans with different superscripts are significantly different by group using independent t-
test at p<.05.
Table 13.
Month
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Control
(n==12)
0.9 ± 0.83
0.5+1.1 3
0.4 :; 0.7b
Behavioral
(n==6)
08 ±0.4 1,3
1.0 ±0.93
1.7 + 1.03
Dietary adherence score by study group.
Month
Baseline
Month 6 (last contract)
Month 8 (post)
IMean ±standard deviation.
3Means with different superscripts are significantly different by group using independent t-
test at p<.05.
Table ]4.
Control
(n==12)
1.6 ± 1.23
1.4 ± 1.8a
1.0 ± 1.3b
1.5 ±0.51.3
1.7±I.S3
3.5 ± ] .93
Behavioral
(n==6)
Month
Baseline
Month 6 (last contract)
Month 8 (post)
Table ]5. Total adherence score by study group.
lMean ± standard deviation.
3Means with different superscripts are significantly different by group using independent
t-test at p<.05.
::
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CHAPTER V
DISCUSSION OF RESULTS AND IMPLICATIONS
Behavioral contracting did not significantly change illness intrusiveness or self-
efficacy in the present study. However, behavioral contracting did significantly improve
adherence levels at month six. Behavioral contracting significantly improved dietary and
laboratory adherence in the behavioral group at month six.
This study was conducted to determine if behavioral contracting was effective
method to use when counseling hemodialysis patients to improve dietary adherence.
Total adherence scores were significantly higher in the behavioral group compared to the
control group at month six. Interdialytic weight gain, plasma phosphorus, and dietary
potassium intake were primarily responsible for the higher total adherence score of the
behavioral group at month six. Interdialytic fluid weight gain tended to be lower in the
behavioral group compared to the control group throughout the entire study (Table 7).
Plasma phosphorus was not significantly lower in the behavioral group at post and
delayed post (Table 9). The control group had several non-adherent plasma phosphorus
levels throughout the study, while the behavioral group had one non-adherent level. The
control group received no dietary adherence points for the non-adherent and low
estimated dietary potassium intake at delayed post (Table 3), resulting in a lower dietary
adherence score when compared to the behavioral group. The illness intrusiveness and
self-efficacyihealth belief scores did not increase significantly over the length of the
study and were not significantly changed by behavioral contracting. It is difficult to
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detennine ifbehavioral contracting was an effective counseling method to use among the
hemodialysis population due to the small number of subjects in this study.
Estimated Dietary Intake and Phosphate Binder Adherence
Estimated dietary potassium intake was significantly higher in the behavioral
group than the control group at month six (Table 3). Different factors may have
influenced the estimated potassium intakes. Overestimation of potassium intake in the
behavioral group or underestimation of potassium intake in the control group could be
one reason. Over the length of time of the study, the control group tended to consume less
potassium than the behavioral group. The food frequency form might not have included
some potassium foods consumed by the control group, resulting in a lower reported
dietary potassium intake.
The behavioral group had a significantly higher estimated dietary phosphorus
intake at month six compared to the control group (Table 4). The control group estimated
dietary phosphorus intakes under 1000 milligrams during months four and five. This
could indicate a lack phosphorus in the diet or an underestimation of dietary phosphorus
intake on the FFQ. The significantly higher dietary protein intake reported by the
behavioral group at month six could have contributed to this elevated dietary phosphorus
dietary intake (Table 6). Phosphorus binders may have played a role in the laboratory
phosphorus levels. The phosphorus binders bind to phosphorus that was consumed in the
dietary protein, reducing the amount of phosphorus absorbed into the body. The
behavioral group reported 100% adherence with their phosphorus binders which could
have accounted for the lower plasma phosphorus at baseline and month three.
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Both behavioral and control groups reported being adherent with their phosphorus
binder regimen. The control group reported some non-adherent phosphorus binder
behavior during months three, four, and five. During month one, both behavioral and
control groups had non-adherent plasma phosphorus levels which could indicate a false
reporting of phosphorus binder use.
Interdialytic Weight Gain
Average interdialytic weight gain ranged from 2.3 kgs to 2.9 kgs for the
behavioral group and 3.0 kgs to 3.8 kgs for the control group (Table 7). The interdialytic
weight gains in the present study were greater when compared to other studies. Hegel et
a1. (2) found that the average interdialytic weight gain was 1.68 kilograms per 24 hours
among subjects. Caeser et a1. (70) found that in-center hemodialysis patients had an
average daily weight gain of 1.2 kgs per day which was non-adherent compared to the
adherent weight gain guidelines ofless than 0.9 kgs per day. The interdialytic weight gain
"as significantly lower in the behavioral group at month six and post. Behavioral
contracting might have been a factor in lowering the fluid intake of subjects in the
behavioral group, however, the interdialytic weight gain tended to be lower in the
behavioral group throughout the entire study, although not significant. The interdialytic
weight gain calculation was not calculated on a day to day basis, so the control group
could have had more weekend periods of interdialytic weight gains recorded in this study
than the behavioral group.
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Laboratory Values
Few studies reported laboratory values obtained in ESRD patients. In the present
study, plasma potassium levels ranged from 4.4 millimoles per liter (mmol/L) to 5.6
mmol/L in the behavioral group and 4.6 mrnol/L to 5.0 mmol/L in the control group
(Table 8). Brown and Fitzpatrick (I 9) defined criteria that was used to assess and score a
patients' level of dietary abuse. Patients received I point if their plasma potassium was
less than 4.5 mmol/L, 2 points if their plasma potassium was 4.5 to 5.4 mmol/L, 3 points
for a plasma potassium of 5.5 to 6.0 mmollL, and 4 points for a plasma potassium level of
greater than 6.0 mmol/L (19). The more points a patient accumulated, the higher their
level ofdietary abuse (19). Brown and Fitzpatrick (19) reported that 58% of subjects
showed some degree of dietary abuse with a plasma potassium value ranging between 5.5
to 6.0 millmoles per liter. In the present study, the percent of participants that were
categorized as non-adherent based on plasma potassium, was not determined. The use of
laboratory adherence score was used in the present study.
Plasma phosphorus tended to be higher in the control group throughout the study
with the exception of month two when the control group tended to have a lower plasma
phosphorus level (Table 9). The behavioral contracting might have been a factor in the
lower plasma phosphorus levels reported in the behavioral group. Elevated plasma
phosphorus in the control group could have been associated with tissue catabolism, bone
disease, or hyperparathyroidism.
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Illness Intrusiveness
Illness intrusiveness scores were not significantly different between the
behavioral and control group during the study (Table 11). The illness intrusiveness
scores ranged from 41.7 to 46.7 for the behavioral group and 35.2 to 46.8 in the control
group. Subjects in the present study had higher illness intrusiveness scores when
compared to other studies. This means subjects in the present study perceived the
hemodialysis regimen to be more intrusive when compared to other studies. Devins (8)
reported a mean illness intrusiveness score among in center staff care hemodialysis
patients to be 36.4. Devins et a1. (62) concluded that subjects who experienced
headaches and cramps on dialysis had a higher illness intrusiveness score (46.9) than
those who did not experience them (28.4). Devins et a1. (56) found that ESRD
individuals who had episodes of restless sleep reported significantly higher II scores
(44.0) than those who did not (35.3). Devins et al. (58) reported a significant difference
in II scores between in-center hemodialysis patients with a mean II score of 35.9 and post
transplant patients who had a mean score of24.4. Subjects who experienced conditions
associated with hemodialysis treatments had similar levels of illness intrusiveness. None
of these were measured in the present study. Subjects in the present study might have
experienced cramping, low blood pressure, nausea, vomiting, headaches, a clotted
kidney, or some other stressor during their dialysis treatments causing their perceptions
of II to be high.
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Self-Efficacy and Health Belief
Self-efficacy/health belief scores were not significantly different between the
behavioral and control group in the present study. Self-efficacy/health belief scores
ranged from 29.5 to 33.0 in the behavioral group and 27.5 to 31.2 in the control group
and the higher the score the greater the self-efficacylhealth beliefto follow the renal diet.
Tanner et al. (5) found that the mean self-efficacy score among the hemodialysis patients
in the behavioral group was 18.43 and] 8.3 in the control group, which agrees with the
present study. Caesar et al. (70) found that in center hemodialysis patients' had a
moderate amount of self-efficacy using the patient self-efficacy questionnaire (PSQ)
which is a different self-efficacy scale than the one used in this study. Reliability for the
PSQ has not been established (70).
The subjects in the present study reported a higher level of self-efficacylhealth
belief when compared to the subjects in Tanner et aJ. (5) and the same instrument was
used in both studies. Some of the subjects in the present study might have experienced
life events that could have altered their confidence about following the renal diet during
the present study, resulting in a high level of self-efficacylhealth belief. For example, an
increase in social support, finances, marital status, adequate counseling and support from
dialysis center staff, or decreased duration of dialysis treatment.
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Behavioral Contracting, Illness intrusiveness, Self-Efficacy, Health Belief, and
Adherence
The use of a behavioral contract in this study did not result in a significant
difference between groups in self-efficacy/health belief, or illness intrusiveness scores.
The behavioral contract did result in a significant difference in adherence scores between
groups. Based on the present study and other work, results remain inconclusive when
using behavioral contracts among hemodialysis patients. Other studies that had success
with behavioral contracting offered a reward to their subjects for achieving their
behavioral contract goal (30, 48, 49, 50, 51). The subjects in the present study did not
receive a reward except verbal praise from the dietitian or dialysis staff for obtaining their
monthly behavioral contract goals. Perhaps if a reward was offered, the results would
have been significantly different. Tanner et al. (5) agrees with the present study in that
they found no significant differences between the behavioral and control gToup for
monthly phosphorus and fluid weight gain values despite the self-monitoring tool and
behavioral contract. Tanner et al. (5) also found no significant differences in self-
efficacy/health belief scores between study groups despite the use of a self-monitoring
tool and behavioral contract in the behavioral group. Keane et al. (52) reported
significant differences in interdialytic weight gain when behavioral contracts were
initiated in hemodialysis patients.
Several factors may influence why behavioral contracts were inconclusive in the
hemodialysis population. Each research study might have used a different behavioral
contract with their dialysis patients instead of a standard contract. Some studies might
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have offered rewards or incentives with the attainment of a behavioral contract goal
where others did not. Social praise by the dialysis staff may have been included in the
methods of some studies where no social praise was offered in others. However,
behavioral contracting has been shown to be successful in a variety of other acute and
chronic disease states (30, 48, 49, 50, 51).
Limitations
This study included only hemodialysis patients from Saint Francis Hospital in
Tulsa, Oklahoma who volunteered to participate, thus results were not generalizable to
other dialysis patients. Seasonal changes in dietary patterns was not taken into
consideration in the present study with all subjects starting and finishing the study at the
same time. Subjects who volunteered for the study, tended to be more adherent than the
people who did not volunteer. The accuracy of the food frequency questionnaires was
limited due to the subject's inability to estimate and record daily food intake. The
accuracy of the illness intrusiveness and self-efficacylhealth belief surveys were limited
to the subject's ability to interpret and answer the questions. The self-efficacylhealth
belief scale does not have high reliablility across all sections. Positive social feedback
from the staff and dietitian to the subjects was not regulated in the present study. The
interdialytic weight gain was not calculated on a per day basis and makes comparisons
difficult. Some of the comparisons may have resulted in no significant difference due to
the limited number of subjects who participated in this study.
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Recommendations for Future Research
A more comprehensive and valid renal food frequency questionnaire needs to be
developed to allow for more serving sizes and food varieties. A more developed food
frequency questionnaire would provide a more accurate dietary assessment of the
patient's actual food and nutrient intake. Future researchers should use a larger number
of subjects and control for length of time the subject had been receiving dialysis
treatments, since patients who were on dialysis for a longer period of time may have
different views and beliefs about dialysis. The principal investigator should calculate the
interdialytic weight gain on a per day basis to account for different lengths of time
between dialysis. Recruit a higher number of subjects to account for drop out rate when
determining the number of subjects needed for the study. A self-efficacylhealth belief
scale with higher reliability on all sections is needed. The behavioral contract increased
the knowledge of dietary potassium, phosphorus, and protein of the behavioral group
resulting in more accurate food frequency questionnaire estimation. Future studies need
to develop a survey to test the dietary knowledge between the behavioral and control
groups regarding dietary sources and serving sizes of potassium, phosphorus, and protein
foods.
Further research needs to be conducted with the ESRD population to learn more
about the psychosocial effects that the disease and treatment regimen have on the patient.
Once the psychosocial effects are understood, patient education materials could be
developed to minimize these effects, possibly resulting in an increased level of treatment
adherence. Also, the dietetics profession could educate dietitians on effective counseling
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behaviors to practice with these patients in order to maximize their level of dietary
adherence.
Implications for Practice
Based on the results and experience gained in the present study, implications for
practice were developed by the author. Future researchers should have the subject focus
on one behavioral change in the behavioral contract so the subject does not become
confused and forget which behavior to work on. If more than one behavior is allowed on
the behavioral contract, it is difficult to determine if the behavioral contract goal was met
if the patient achieved one behavioral goal but did not achieve the other. The dietitian
should conduct all surveys with each subject to minimize confusion regarding some of
the questions and consistent answers can be achieved since the surveys are repeated
throughout the study. The principle investigator should include a reward if the subject
achieves the goal set on the behavioral contract from month to month.
Dietitians could use behavioral contracts in other chronic disease populations such
as diabetes. Diabetic patients could define dietary behavior changes to improve blood
glucose levels. Behavioral contracts would be an excellent tool for outpatient dietitians
to use with their patients. The patient could define a dietary behavior change on the
behavioral contract and work on that dietary behavior between appointments. The
dietitian could monitor the success of the behavioral contract when the patient returned
for their follow-up appointment.
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-Appendix A
Recruitment Flyer
-.~re you having trouble lvith potassium,
phosphorus, protein, or fluid \Yeight gain
in your diet?
"':hy? You are invited to participate in a research srudy that is
designed to detennine if a behavioral contract will improve your renal diet
and problems with potassium, phosphorus, protein, and fluid levels.
Benefits cannot be promised.
How? This study will assign half of the participants to use a
behavioral contract. A behavioral contract is a signed agreement between
you and the investigator dietitian (Lesley). It is designed to help you set
goals to improve specific laboratory values. This study will also look at
your perceptions and beliefs about hemodialysis. This study will require
your time to complete surveys during your routine hemodialysis treatments
at Saint Francis Hospital.
Wh0 ? All hemodialysis patients in the outpatient dialysis unit at Saint
Francis Hospital will be invited to participate. Patients must be able to
communicate and complete the surveys with the investigator dietitian.
Patients who are currently on nutrition support (tube feeding or rnA) are
ineligible to participate in the study.
When? The study will begin in April 1999 and end in February 2000.
A voluntary consent form will be given to you in the next couple of weeks.
This consent form will explain the purpose of the study. It will also explain
the requirements of each subject if they choose to participate. Participation
in this study is strictly voluntary.
Contact
If you would like more information about participating in this research
study, you may contact: Investigator- Lesley Hoyle RDILD at Saint Francis
Hospital, 6161 S. Yale Ave., Tulsa, OK 74136, phone number- 494-7202.
Lesley is a Registered Dietitian at Saint Francis Hospital and a graduate
student at Oklahoma State University.
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Consent Fonn
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PATIENT CONSENT OOCUMENT
The Effect of Illness Intrusiveness. Self-Efficacy, and Behavioral Contracting on Dietal"'j
Adherence in Chronic Hemodialysis Patients
APR 2 7 1999
Voluntar'j Participant -:-----==--- ----------4-----
Principle Investigator. Lesley Ramsey RDILD
You are being asked to participate in a research study. Your decision to take part in this study is
entirely 'Joluntary. Please read carefully the information provided in this document and ask
questions about anything you do not understand or any words that you do not clearty understand,
~fore deciding whether or not to participate.
INTROOUCTION: Patients with chronic renal disease who are on hemoclialysis must follow strict
regimens including treatment schedules. medication. diet and ftuid restrictions. These
restrictions, especially the diet require a significant change of lifestyle for the patient Patients
who make the appropriate 1ifesty1e changes necessary for the adjustment to hemodialysis,
improve their healttl and quality of life while on dialysis. It has been reported that between 20-
78% of hemodialysis patients do not follow their diet and ftuid ltIerapy because of the alteration in
their long-standing personaJ habits and life style.
1. PURPOSE
You are invited to participate in this investigational research study. This study will evaluate
behavioraJ contracting by t1emodiatysis patIentS for managing their diet to see if it effects their
perception of life with chronic renal disease and their effectiveness of managing their disease.
The pUfl)ose of the study is to determine if hemodiaJysia patients who use iii behavioral
contract will improve ltIetr dietary adherence. Approximately 74 patients at Saint Francis
Hospital will be invited to participate in this study, with a goal of at least 40 patients wiDing to
participate.
2. DESCRIPTION OF STUDY AND PROCEDURE(S)
It is not dear at the present time if the behavioral contracting will be etrective in improving
dietary compliance. For this reason. half the patients who participate in this study win be
assigned to the experimental group using the behavioral contrad tool and the other half wiD be
assigned to the control group using no contract tool. Your assignment will be based on
randomization . RandomiZation is a statistical method. like a toss of a coin. which wilt assign
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]rSL;C 3r~ 3ccrr;:<::-a[=I~1 =GL.al
i:-'Is .5tuC'! ,vIii lce .-esl.lln any :reacmenr changes :or ;Jattents .3SSI~ned :0 21lher3rcup.
Ail ::latler,cs snculd 3chere :0 :heir '.Jsual regimen 'Jf dialysIs :reatmentncluding: meClCations.
renal diet. fluid ;esm~cn. and hemodialysIs treatment schedule.
Experimental Group 1- Using Behavioral Contract Tool
If you are 3ssigned :0 ttlis group you will complete a behavioral contrac: with the
investigator dietitian 2very month for six months while on ttle study. This contract wilf be a
written agreement, negotiated, individualized. and private between ltle patient and investigator
dietitian. This contract will specify expectations and plans for the behavior to be changed.
Control Group 2- Using No Tools
If you are assigned to ltlis group you will not use the behavioral contract toel, however.
data will be collected to use as comparison with group 1.
Both Group 1 and 2
You will be asked to complete a personal information record during the baseline month
of the study which Will ask you about yearly income, age, race, gender, medication schedule.
dialysis treatment schedUle, diagnosis leading to dialysis, nephrologist. and marital status.
You will be asked to complete a food frequency fom1 during the baseline manttl and
months 1,2,3,4,5,6 and 8 or the study. The food frequency fonn will require you Ie estimate
the types of foods that you have eaten during the previous month. You will be provided with
tood models and instructions to assist you in completing this form.
'(.ou will be asked to complete two surveys during Itte baseline mon1h and months 1, 3,
6, and 8 of the study. These surveys WIll ask you questions about your views and perceptions
of hemodialysis and renal disease,
Data will be obtained from your medical records starting with records (or the four
months prier to participation and continuing throughout the duration of the study to include
diagnosis, treatment related to dialysis, medications. weights. and laboratory data which is
colleded routinely once a month.
Your participation in this study will last 10 months.
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:Ja[:er.[ :]ata.please see ::nridentlalit'j sectlcn of consent fOnll). Nc ~xtr3 'acorator'j :eSiS are
reqUired for data collectIon. The study will involve some of the patient's time during the
dialysis treatment to complete the necessar/ surveys and forms required in the research
5t1JCY There are no extra costs related to your participation in this study.
4. BENEFITS
Benefit cannot be promised. Possible benefits are prolonged survival, relief of symptoms
caused by dietary non-compliance. and more control over your disease.. Some other benefits
include an increase in quarrty of life and a decrease in the risk of morbidity and mortality.
Another potential benefit is knowing more about yourself, your beliefs about dialysis, and more
about the renal diet and dietary compliance.
5. CONFIOENTIALITY
All information collected from your involvement in this study will be kept confidential. By
signing this document you consent to such review. This consent will be flied in an area with
access restricted to the Principallnvestigatcr and authorized representatives. Your identity will
be kept confidential unless discfosure is required by law. You win not be identified in any
publications resulting from this study. All data collectec:l from this study wtG be kept in a Ioc:ked
file that win be kept in the principle investigator's offtc:e. A code number will be assigned to
each subject. Only the principle investigator and the subject will be aware of their code
number. By using this code number system, all data collected will be kept confidential.
8. CONTACT PERSON: For mote infonnation about 1his study, you may contact: LBsJey Ram&eY
RDIlD at Saint Francis Hospital, 494-n02, Dr. Kathryn Keim PhD RDIlD Oktahoma StBte
University, 405-744-8293,. You may aJso conta<:t the Institutional Review Board of Saint Francis
Hospital at 918-494-2495 and/or Sharon Bacher. 203 Whitehurst. Stiflwtrter. OK. 405-744-5700 I'cr
information about your rights as a research subject.
7. NEW INFORMAnON
You will be informed of any new findings developed during the course of this research which
may relate to your willingness to continue participating in this study. The investigator may
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a. VOLUNT,,),RY PARTICIPAnON
Your particIpation In this study 15 voluntary. You have the right to decide If you want to
participate in this study. You also have the right to stop taking part in ttlis study any time you
choose 'Nithout penalty or loss of benefits or treatments to which you are otherwise entitled.
At no time will your medical care be at risk based on your decisions. In ltle event you withdraw
from the study. clinical data will continue to be collected unless you specify otherwise. You
hav.e ttle right to refuse any further involvement .
. .. ....... •• ••
I have read all of the above, asked questions concerning areas I did not understBnd. and wHUngly
agree to participate in this study. By $igning this fbnn , understand there is go gulJJ7JtttH I wf11 be able
to participate in this st1Jdy. There may be heeJth or trNtment COIJfJitioM in my case which could make
the study unsuitable fer me. I will be given a copy of this signed consent form for my ffICOfds.
Patienfs Signature
Principle Investigator's Signature
WItness's Signature
Date
Date
Date
Page 4
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resear-::l let..; are ~nmtec :0 :ertaln1gms NnIC," .nc:L.ce jlJt are :"let :irr.ltea :0 :he fcllcwmg:
Tne 19ht :0 be informed of the nature and purpose of the research.
2. The tight to be given a full explanation of the procedures to be followed including the use of
any jrug or device.
3. Tne right to be given a description of any reasonably expected or potential discomforts and
risks and any alternative treatment available rt complications arise.
4. The right to be given a description of any reasonable expected benefits.
5. The right to be given a description of any appropriate alternatives including alternative drugs
or devices.
6. The right to be informed of any new infonnation developed dUring the study which may relate
to your willingness to continue participation.
7. The right to be informed how information obtained from your involvement in the study will
remain confidential.
8. The right to be informed of any additional costs as a result of your participation in the study.
9.. The right to an explanation of any compensation or treatment that may be available if injury
OCCUI"5.
1O. The right to ask any questions either prior to granting consent or thereafter concerning the
research and the procedures involved.
11. The right to refuse to participate or to withdraw from the study at any time without penalty or
loss of benefits to wttich you are otherwise entitted.
12. The right to consent or to refuse consent to participate in the research study without the
influence from improper persuasion.
13. The right to a copy of your signed and dated consent form if you volunteer to participate.
The Institutional Review Board is a group of physicians and lay people who are committed to the
protection of human subjects and must review all clinical research projects and the consent
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Institutional Review Board Approval Letters
Oklahoma State University
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Kathryn Keirn
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The above referenced proposed research project has been reviewed by a qualified
member of the IRB in accordance wittI this institutions policies and procedures and the
federal regulations.
The IRB member has determined that
__The proposed study does NOT meet criteria for expedited approval and is
scheduled for full board review.
/ The proposed study IS APPROVED for 12 months as submitted,
The IRB member determined the next review date will be on or before a 1~H40
The attached guidelines are applicable for research approved by this IRB. Failure to
follow these guidelines could result in automatic termination of your research project..
G. Kevin Donovan, MD, GeneraliRB Chair
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Behavioral Contract
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[ will make the :oHowing monthly changes to improve my monthly progress repor:.
Goals(s): _
Signature ofpatieat: Date: _
SignabJre ofRD: Date: _
FlU:
GoaI(s) met GoaI{s) not met _
Commetlts (Reasons why goal met or not metlfuture goals): __------
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Personal Information Sheet
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Personal Infor711atcr:
Nar.:e _
Personal Information
Code number
---
Directions. Circle the number that will answer the question or fill in the blank.
1. Gender
1 female
2 male
2. Age.__{in years)
3. Ethnic Origin
1 VVhite
2 Black
3 AsianIPacific Islander
4 ~rmrmN~Nawe
5 Hispanic
6 Other, specify _
4. Marital Status
1 single
2 married
5. Primary diagnosis leading to cftalysis treabn8nt
9. Year and Month started dialysis trNbnents
10. Ler.gtt. of current dialysis treabii8t.ts hourslper visit
11. Number of time per week i~ dialysis __~
87
12 Cur;-2nt:r.cs::ncrus binder
----
1J :-:cw ;-:a("/ :rcs~r.orus bir.cers ar2 ~ak2~ at break7as~"
--
14. How many phosphorus binders are taken at lunch?
--
15. How many phosphorus binders are taken at dinner? __
16. How many phosphorus binders are taken with snacks? __
17. VVhat is your current dry weight? (Circle if pounds or kilograms)
18. Household Income (dollars per year) check one:
1 less than 14,000
2 15,000-19,999
3 20,000-24,999
4 25,000-29,999
5 30,OO~34.999
6 35,000,39,999
7 4O,Q00-44,999
8 over 45,000
16. Primary Physician (Nephrologist) _
88
Appendix F
Illness Intrusiveness Scale
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Tne following Items ask about now much vour illness and/or Irs treatment Interiere
with dirrerent aspects or 'lour lire. PLEASE CIRCLE THE ONE ,~UMBER THAT BEST
DESCRIBES YOUR CURRENT LIFE SITUATION. If an item is not applicable, please circle
the number one (1) to indicate that this aspect of your life is not affected very much.
Please do not leave any item unanswered. Thank you.
_ How much does your illn~MId/or in trHtm@nt int.mn with ,our:
1. HEALTH
Not Very Much T 2 3 5 6 7 Very Much
2. DIET (i.e., the things you eat and drink)
Noc Very Much
3. WORK
Not Very Much
2
2
3
3
4
4
5
5
6
6
7 Very Much
7 Very Much
4. ACTIve RECUATION (e.... sports)
Not Very Much 2 3 4 5 6 7 Very Much
5. PASSIVE RECREATION (e..., ~inL listening to music)
Noc Very Much 1 2 3 5 6 7 Vety Much
6. FINANCIAl SITUATION
Noc Very Much 1 2 3 4 5 6 7 VetyMuch
7. lELA110NSHIP WITH YOU. SPOUSE (Jirtfriend or boyfriend if not rTWTied)
Not Very Much
8. SEX UFE
Not. Very Much 1
2
2
3
3 4
90
5
5
6
6
7 Vety Much
7 VetyMuch
How ;nuc.i ioes 'jour illness J.ndior its lreJ.(m~nt interfere with your:
9. F...~.:"\l LY RHAnONS
Noe Very Much 2 3 4 5 6 7 Ve,ry Mud1
10. OTHER SOCIAL RELATIONS
Noe Very Much 2 3 4 5 6 7 Very Much
11. SElF-EXPRESSIONISELF-IMPROVEMENT
Noe Very Much 2 J 4 5 6 7 Very Much
12. RELIGIOUS romslON
Not Very Much 2 3 4 5 6 7 Very Much
13. COMMUNITY ANO a\l1c INVOLVEMENT
Not Very Much 2 3 4 5 6 7 Vet)' Much
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Appendix G
Self-Efficacy Scale
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[0 :;: D.~T~
SELF-EFFlC.\CY .-\:"iD HEALTH BELIEFS SLRVEY
This mfor:naucn ~:) compl~t~!'1 ccnfidential [v.ill not record ,-,our name. The answers vcu
J • •
give will not wee: the care you receive in the dialysis unit. .~k me to explain anything
you do not understand. There are no right or wrong answers. Thank you for your honest
answers.
Listen to each statement carefully. Please tell me how important each statement is to you.
Example:
I think it is important to wear a seat belt when I drive.
I-VERY IMPORTANT
2-S0METlMES IMPORTANT
3-NOTIMPORTANT
KEY:
1 - 9 HB SCORES
10 - 22 SE SCORES
1.
2.
It is important to me to be healthy.
It is important to me DOt to itch.
1
1
2
2
3
3
3. It is important to me to limit foods high in phosphorus such as cheese, milk. ftesh
peas and beans, chocolate and dark-colored sodas, to help prevent brittle bones,
bone pain, and itching.
1 2 3
4. It is important to me to limit my fluid intake ofwater. tea, juice. ice, sodas. IDd
jello so that I will not have cramps when 00 dialysis.
1 2 3
S. It is important for me to take my calcium pills with my meals to keep my
phosphorus down and my bones healthy.
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1 2 3
7.
J
Ct [S imp~~t to me not to gain coo much fluid weight between dialysiHessions
because It IS dangerous and can weaken my heart.
1 2
8.
9.
If I.ron out ofmy calcium pills. it is important for me to let the doctor. DW'Se, or
social worker know right away.
1 . 2 3
I am at risk for boDe~ stroke. heart &iIure, IUd death ifl do DOt renew my
diet. &mit my fluids. come fix'.diaIysis. aDd take my EDedications. •
1 2 3
Tjstea to each stateme:ut cardWIy. Please tell bow oftm you feel you CaD do ada oCtile
tbllowiDg stltemeilb
I-ALL OF THE TIME
2-S0ME OF TIlE TIME
3-NONE OF 11IE TIME
10. I can limit the IJDOUDt offluid I drink each day.
1 2 3
11. I can chew gum, eat bard caDdy. or rime my DDltb with moUtbwuh wbeD I IDl
thirsty to prevent me from drinking too much.
1 2 3
12. I CID tab my can,," pins to keep my pbospborus dowD.
1 2 3
13. -I can make cbaDga in the foods that I eat ad cIriak to help coatrolmy fluid mire
aDd improve my moath1y lab work and fluid pm.
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1 2 3
15 I k.,ow what toads nor to C:3.C to keep my phosphorus in good concrol, and I believe
that I can control my phosphorus with my diet.
1 2 3
16. I can remember to take my calcium pills with each meal as prescn"bed.
1 2 3
17. I can still follow my diet when eating out and away from home.
1 2 3
18. I can keep up with how much fluid I gain in between dialysis, and ifmy calcium is
too low and my phosphorus is too high..
1 2 3
19. I can set a goal to decrease my fluid intake aDd gradually start cutting back: to rach
that goal.
1 2 3
20. I can make a goal to carry my calcium pills with me everywhere I go so that I will
have them when I eat a meal.
1 2 3
21. I can replace cae &write hisb pbospborus food (like ice cream or cbocolate) with
a food low in phosphorus (like sherbet or bard candy).
1 2 3
22. I can limit the amount ofsalty foods I eat. like bot dogs, bologaa. bacon. aDd.
potato chips to help prevent thirst.
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1 2 3
Appendix H
Food Frequency QuestioJUlaire
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Roberts D. Jensen 1. Renal tood frequency fonn. Journal ofRenal Nutrition. 1997; 7
(4): 221-222.
.J _.:= - '. ".~=
! '.IL'L ~:?~'"' :'~~~'.'
=';I:C -\.\.!f; 1.:'-.-5 ! Sc:It:::: DA1L y ?~O K' P10S I ?'lO K' ?~os ,I
.'vIii\.: . .J. ,n. J. ic: C~:Jm ~ I I , :; ~ ;1 2 I I-
I : ~ ard C:le~se l.-\menCJn. @ I I
... :; .J. 7 I ,
I
-
-I
: SWISS. Chedd.ar. elc.)I
I
I :=:sh oz. ~ I ... ] .1 7 l II (Inc!uciing tuna) - ~ oz.
:r. I Turxc\'
I
...z oz.~ I ] 4 • • ~- I • -:: I Chicken
0 Cold CULS ~ I 2 J 4 ~ ~ •::: HOI Dogs. S.lusage
-
Meat oz. ~ I 2 J 4 I ~ •
Eus O~ 1 2 3 4 I I •
CaMcd Fruit. . . II! cup &0 I 2 3 4 - 2 -en Apples. Grapes. Berries~
..J Oranges. Pruocs. 2 J 3= fdO I 4 - -< Pears. PeachesEo-
~ Banana. Melon. e)) I 2 3 4 4Co' - -~ Dried Fruit
>-
Q Lettuce. Cabbaae. Celery. {S)fJ 1 2 3 4 - 1 -Z Euplanl. Pepper. Zucchini<
~ Tomatoes. (urou.~ 1 2 3 4 - 2 -:... Green Beans. Peas~
s: Broccoli, dB1) 1 2 3 4 - 2 -Cauliflower
Dried Peas. Beam cQ) 1 2 3 4 2 4 2
Powoes, Yams ~ I 2 3 4 2 4 1
Bread. Rolls, ~ I 2 3 4 2 1 112~ CracKers. TortillaCereal e!3 1 2 3 4 I , ,U~ Noodles. Macaroni~ I 2 3 4 , , •~ In cup
Rice ~ 1 2 3 4 I I ,
l~lOO 1 pc
RANGK K -/Phos 1l~200 2pc TOTA1S
210-300 ]pc .
-
PRo K- nos
Figure 2. A blank rOO<! frequency !orm. As shown in the sample (FlQUre 1). the values for protein (PRo.).
potassium (K-). and phosphorous (Phos) are multiplied by the number of servings 0' dIII.rent roods. Food IS
grouped into flROT'ElNS, FRUITS AND ~GETA8LES. and STAIlO4ES.
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Appendix I
Approval Letters from Nephrologists
and Dialysis Unit Manager
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Saint Francis
Hospital
~ 161 ;outh fale Av~nu~
·ull.J.OI( '4136
~ 18.494.~200
NWW.sainrlrancis.com
j
~~ Saint Francis
=f Health System'
found~d I7y ""~ 'Ni/liam I( Warrt" - ,
11/10/98
Oklahoma State University Institutional Review Board:
This letter is in regard to Lesley Hoyle's research for her muter's degree. Her research will be
conducted in the Renal Dialysis Outpatient Unit ofSaint Francis Hospital. Lesley is the renal dietitian for
the outpatient dialysis unit and inter3dS with the patients on a regular basis. Her research will involve
obtaining montllly biochemical dm &om each patient, bodily wei&hts. inla'Viewing, and surveying each
patient involved. However, the dialysis unit dnW1 monthly labs and weigtu the patients IS a part ot'the
standard operating procedures.. Lesley will be using these month.ly labs in order to collect the biochemical
datil. she needs for her researdL lbcrefore. she will not be conductinc any 1&bonrory tesU on die ~ts.
just using the biochemical data that is collected by the unit every monch. Her research does not require any
exira procedures or risks to the patients. If you have any lW1her questions about any of the standard
operating procedures of the outpatient diaJysis unit, please conlact KmIy Sittler. Dialysis Unit M.,qer. 11
91&-494-5571J. Thank You.
Robert M. Gold M.D, F.A.C.P
Tulsa Nephro1ocY, Inc.
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Saint Francis
Hospital
.;:., I :OuCh "JI~ ..\v,!,nue
-III'.l.':1( "-II :6
} 18.-194 ~200
IYWW. lain Ifra nCI I.com
)
~~ Saint Francis
f Health System'
11/10198
Oklahoma State University Institutional Review Board:
This letter is in regard to Lesley Hoyle's research for her master', degree. Her research will be
conducted in the Renal DialY3i.s Outpatient Unit ofSairu Francis Hospil3.l. Lesley is the renal dietitian for
rhe outpatient dialysis unit and inlerKt:l with the patients on a regular basis. Her research will involve
ob13ining monthly biochemical data from each patient. bodily weights. interviewing. and surveying each
patient involved. However, die dialysis unit draws monthly labs and weighs the parien13 as I put oflhe
standard operating procedures.. Lesley will be u.sing these monthly labs in order to collect the biochemical
daIa she needs for her rcseardI. Therefore, she will not be conduc:tinS any IaboraIory tesu on the patieats,
just u.sing the biodlemical data that is collected by the unit every month... Her research does not require any
atra proccdura or risks to the plDCUIS. Ifyou have any fiuther qucstioas about any of the standard
operating procedures ofthc OU1p8bcut dialysis unit, please conlBCt Kalhy SiuJer. Dialysis Unit Manacer, It
911-494-SS79. ThaD.k You.
Sincerely.
Tulsa NepbrolocY. IDe.
100
Saint Francis
Hospital
; ;; jouth '(ale -\venue
-"lId. 'JK "41)6
J\3.-l94 :200
www.SdlntfranClS.com
I
~~ Saint Francis
~ Health System"
KJundtd Oy me William .( 'Namm
I 1110/98
Oklahoma Stale University Institutional Review Board:
This letter is in regard to Lesley Hoyle's research for her master's degree. Her research will be
conducted in the Renal Dialysis Outpatient Unit of Saint Francis Hospital. Lesley is die renal dietitian for
the outpatient dialysis unit and interacts with die patients on a resular buis. Her research will involve
obtaining monthly biochemical data &om C8Ch patient. bodily weigha. interviewing. and surveying each
patient involved. However. the dialysis unit draws monlhly fabs md wei&fu the patiCllts IS I pan of die
standard operating procedures. Lesley will be usinalhese monthly 1abs in order to collect the bioc:tlemicaJ
data she needs for ber resean:h. Therdore. she will noC be conductin& my laboratory tests on the patients,
just usinl the bioc:bemical data !hal is collected by Ute uail every mllllth. Her raareh does not require any
extra proudures or risks to the.,.Deats. Ifyou bayc any l\uther qucstioas about any of the saandard
opcnring procedures o{the ouq,uieat diafysis uait, please contact Kadty Silder, Dialysis Unit Manager. I.t
911-494-.5579. ThanIc You.
Sinc:uely,
f~~
Kathy SitlJcr RN. BSN. CNN
DiaJ}'3is CIiDica.I Direc:ccf
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Appendix J
Monthly Laboratory Report
J02
-Test
I
Goal I Diet Sources How To ::orrect Abnormal:Range I LevelsI I I
Potassium 3.5 . 5.5 . C<Joked dried beans. I Higb: OmIt .1lgh potassium foods
potatoes. bananas. orange High ievels ::m :ause :ardiac an-e$t
juice. cantaloupe:. w/Chow p!rysic::zi symptoms
tomatoes Low: [ncrease intake of high
(many fresh fruits & pocassium foods. Diarrhea &lor
vegetables) vomiting can cause potassium todecrease
BUN 60 - 90 Low quality protein - H.i&b: Avoid low quality protein.
(Blood Urea beans,Duts,seeds Limit high quality protein to within
Nitrogen) meal plan. May cause TfmISeQ,
High quality protein - lIomiting. taste changes. iJdung. or
meat, eggs. milk, poultry confusion
&fish Low: Increase intake of high qualityprotein foods.
URR >65%
Glucose 65 - 130 Most foods will raise Higb: Limit desserts &: sweets. Eat
(Blood blood sugar, but desserts consistent, well-balanced meals.
Sugar) &sweets have the most iru;lutk protein with eadr meaL
rapid effect Low: Do not skip meals and fol/ow
the same recommendations as above
Albumia > 3.5 Meat, eggs. milk, poultry Low: [ncrease intake of ttigh quality
(Protein) &fish protein foods. Albumin reflects long-
/erm protein inlaJce. Too low i1tcna.tt!S
risk 0/ injection, murde lou. weabrc.s.r
& malrrut1'i/ion
Calcium 8.5 - 11.0 Calcium supplements HiCb: Take calcium supplements only
as prescribed.
Low: Take phosphate binders and
calcium supplements. Cakiwn
g~neraJlygoes up as plwsphorus goes
down.
Pbosphorus 3.5 - 6.0 Milk. cheese. yogurt. ice HiCb: Not taking prescribed
cream. biscuits. salmon., phosphate binders with meals or too
liver, beans, oatmeal. many high phosphorus foods. Cakillm
nuts & bran is rt!mowdfrom the borw.s &: /et!lh
causing weaJare.ss. pain & ilching
Cbolestero.l 140 - 200 SaturaICd fats (animal Hi&b: Use low fat meats and dairy
fats). fried foods. eggs, products. Use canola or olive oil.
liver Limit egg yolks [0 3 per week.
Fluid WL I - 3 kg All beverages. soups, ice Higb: Decrease fluid intake. Limit
Gains cream. jello. popcicles salt. £.xcessjluid causes edl!ma.
snorfl/(:.u ofhrr:atn. increQ.fC work on
the heur!. congestive heurt/ai/UTI!
If you have any questions about this repon or your diet. please contact:
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Lesley Hoyle RDILD 494-n02
VITA
Lesley Kat1u)l1 Ramsey
Candidate for the Degree of
Master of Science
Thesis: THE EFFECT OF BEHAVIORAL CONTRACTING ON ILLNESS
INTRUSIVENESS, SELF-EFFICACY, AND DIETARY ADHERENCE
IN CHRONIC DIALYSIS PATIENTS
Major Field: Nutritional Sciences
Biographical:
Personal Data: Born in Tulsa, Oklahoma, On May 15, 1975, the daughter of
Richard and Joanne Hoyle.
Education: Graduated from Jenks High School in May 1993; received Bachelor
of Science degree in Dietetics from Iowa State University, Ames, Iowa in
May 1997. Completed the requirements for the Master of Science degree
with a major in Nutritional Sciences at Oklahoma State University in
December, 2000.
Experience: Completed a dietetic internship, 1998; employed as a clinical
dietitian at Saint Francis Hospital, Tulsa, Oklahoma, 1998-present.
Professional Memberships: National Kidney Foundation, Council on Renal
Nutrition
